OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION IN TRAUMATIC BRAIN INJURY IN AGING by Shao, Changxing
University of Kentucky 
UKnowledge 
University of Kentucky Doctoral Dissertations Graduate School 
2007 
OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION IN 
TRAUMATIC BRAIN INJURY IN AGING 
Changxing Shao 
University of Kentucky, changing@uky.edu 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Shao, Changxing, "OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION IN TRAUMATIC BRAIN 
INJURY IN AGING" (2007). University of Kentucky Doctoral Dissertations. 533. 
https://uknowledge.uky.edu/gradschool_diss/533 
This Dissertation is brought to you for free and open access by the Graduate School at UKnowledge. It has been 
accepted for inclusion in University of Kentucky Doctoral Dissertations by an authorized administrator of 
UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT OF DISSERTATION 
 
 
 
 
 
 
 
 
 
 
Changxing Shao 
 
 
 
 
 
 
 
 
 
The Graduate School 
 
University of Kentucky 
 
2007 
 
 
 
 
 
 
 
 
 
OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION 
 IN TRAUMATIC BRAIN INJURY IN AGING 
 
 
 
 
 
 ——————————————— 
ABSTRACT OF DISSERTATION 
______________________________ 
 
A dissertation submitted in partial fulfillment of the 
requirements for the degree of Doctor of Philosophy in the 
College of Arts and Sciences 
at the University of Kentucky 
 
 
 
 
By 
 
Changxing Shao 
 
Lexington, Kentucky 
 
Director: Dr. Mark A. Lovell, Associate Professor of Chemistry 
 
Lexington, Kentucky 
 
2007 
Copyright © Changxing Shao 2007 
 
 
 
 
 
 
 
 
ABSTRACT OF DISSERTATION 
 
 
 
 
 
OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION  
IN TRAUMATIC BRAIN INJURY IN AGING 
 
 Traumatic brain injury (TBI) is a prominent disease in developed countries, and 
age is an important factor in functional outcome. Although aged patients typically show 
diminished recovery compared to young patients, and have higher mortality and 
morbidity following TBI, the mechanism is not well understood. To date, there is no 
effective therapeutic for TBI.  
 Previous studies indicate a secondary injury in TBI begins immediately after 
impact, and is likely the major contribution to delayed neuron dysfunction and loss. 
Studies also suggest mitochondrial dysfunction and increased free radical species (ROS) 
production following TBI may play a key role in the process. To evaluate oxidative 
damage following TBI, especially in aging, young (3 months), middle aged (12 months) 
and aged (22 months) Fisher-344 rats were subjected to a unilateral controlled cortical 
impact (CCI) injury, and tissue sparing, 4-hydroxynonenal (HNE) and acrolein levels, 
and antioxidant enzyme activities, and DNA oxidative damage were measured. In order 
to evaluate changes in mitochondria following TBI, mitochondrial protein levels were 
investigated using young adult animals. To evaluate a potential therapeutic for TBI, the 
effect of creatine on oxidative damage was evaluated. 
 These studies show an age dependent increase of oxidative damage following 
TBI, demonstrated by increased levels of 4-HNE, acrolein and 8-hydroxyguanine. Middle 
aged and aged animals showed increased tissue loss compared to young animals 7 days 
post injury. Mitochondrial proteins involved in the respiratory chain, carrier proteins and 
channel proteins were significantly decreased 24 h post injury in ipsilateral cortex, but 
increased in both ipsilateral and contralateral hippocampus. To study potentially 
protective compounds in TBI, animals were fed with creatine two weeks before TBI and 
showed less oxidative damage and increased antioxidant capacity, which suggests 
creatine may be a potential drug for clinical treatment of TBI. 
 The work described in this dissertation is the first to show increased oxidative 
damage and diminished antioxidant capacity in TBI in aging. The study of mitochondria 
following TBI using quantitative proteomics is also the first time to show multiple 
mitochondrial proteins change following TBI. These data are also the first to show
creatine can increase antioxidant defenses. These studies contribute to our understanding 
the mechanisms of secondary injury in TBI in aging.  
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CHAPTER ONE  
Introduction and Background 
1.1 Traumatic Brain Injury and Physiological Consequences 
Traumatic brain injury (TBI), also called acquired brain injury or head trauma, 
occurs when a sudden impact results in damage to the brain. TBI can result when the 
head violently hits an object, or when an object pierces the skull and enters the brain. The 
injury can be short term or long term. As a short term injury, patients with severe head 
trauma may die immediately or experience coma for hours and days. Patients with 
moderate or mild injury may experience a loss of consciousness for a few seconds or 
hours. As a long term injury, TBI leads to neuron damage or death at the site of injury 
and adjacent regions of brain, and can be a factor for such neurodegenerative disorder as 
Alzheimer’s disease (AD) (Guo et al., 2000). Clinical studies reveal that survivors of TBI 
may experience trouble in one or multiple areas, including thought and reasoning, 
understanding words, remembering things, paying attention, solving problems, thinking 
abstractly, talking, behaving, walking and other physical activities, seeing and/or hearing, 
and learning (McAllister et al., 2006; Tombaugh et al., 2006; O'Keeffe et al., 2007).  
TBI is the leading cause of injury-related death in developed countries (Das-
Gupta and Turner-Stokes, 2002), accounting for 26% of all trauma-associated deaths in 
the United States (Sosin et al., 1989; Sosin et al., 1995). TBI is also a major cause of 
persistent functional disability and psychological impairment (Harvey, 1986). Recent 
statistics show that motor vehicle accidents (~60%), falls, assaults and various sports-
related injuries (40%) result in TBI that affects ~ 7 million individuals each year in North 
America (Tibbs et al., 1998; McNair, 1999). Approximately 70,000 to 90,000 of those 
injured suffer long-term disability.  The cost to treat these individuals is estimated at ~ 
$20 to $25 billion annually (McIntosh et al., 1996). In the last 30 years, our 
understanding of the physiopathology of TBI has greatly improved, but the mechanism of 
injury, particularly delayed injury, is still unclear. The improved outcome of patients with 
severe TBI has reached what looks like an unmodifiable plateau resulting from limited 
understanding of the neurological and neurochemical cascades triggered by primary 
mechanical injury. There is still no specific pharmaceutical therapy for TBI and further 
studies are needed for more clues in clinical therapy. 
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1.2 Factors Affecting the Outcome of TBI 
Several factors are believed to be important to the pathogenesis of TBI. Age is 
one of the most widely investigated factors. Age-specific TBI associated death rates show 
a bimodal distribution with peaks at 15- to 24-years of age and >75 years of age (Figure 
1.1) (Sosin et al., 1989). Studies of TBI in young adulthood and elderly patients show 
that very young and old patients are more severely damaged and less likely to recover 
(Hoane et al., 2004; Kirkness et al., 2004; Testa et al., 2005; LeBlanc et al., 2006; 
Thompson et al., 2006). Gender is believed to be another factor that may play a role in 
TBI (Kovacs, 2005; Robertson et al., 2006). Males are 2 to 3 times as likely as females to 
sustain TBI, especially during high-risk years (Thurman, 2001). The reason why age and 
gender affect the outcome of TBI is still under debate. Genetic factors may also impact 
TBI, particularly the presence of apolipoprotein E4 alleles (Diaz-Arrastia et al., 2003; 
Nathoo et al., 2003; Diaz-Arrastia and Baxter, 2006).  Additionally, preventive methods 
are also important to limit TBI. For example, helmet and airbags can greatly reduce brain 
injury. 
1.3  Animal Models of Traumatic Brain Injury 
Because of the limited availability of human TBI specimens, several animal 
models that simulate human TBI have been developed in last several decades with new 
models still under development. 
 For over a century, various in vivo models of TBI have been employed to 
systematically produce pathology of TBI, including fluid-percussion (FP), controlled 
cortical impact (CCI), and weight drop (Awasthi et al., 1997; Scheff and Sullivan, 1999; 
Shimamura et al., 2004). In consideration of experimental design, the species of animal, 
location of injury and choice of anesthesia are also considered. Cats (Bedell et al., 1998), 
pigs (Pfenninger et al., 1989), rats (DeKosky et al., 2004), and mice (Hall et al., 2005) are 
now commonly used animals in studies of TBI. The injury locations include midline for 
whole brain concussion injury and parietal cortex for lateral percussion injury.  For FP 
injury, the injury is produced when a metal pendulum strikes the piston of an injury 
device from a certain height leading to a pulse injection of saline into the closed cranium, 
which induces a brief increase of intracranial pressure with
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Figure 1.1. Death rate distribution of TBI in aging (Sosin et al., 1989). 
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associated displacement and deformation of brain tissue. The severity of injury is 
controlled by the height of the pendulum. The FP injury was first described by Linden 
and Ringer (1965) using a rabbit model of TBI (Carbonell et al., 1998). This model 
produces concussive injury, hippocampal cell death and cortical contusion, vascular and 
blood-brain barrier disruption injury, cerebral edema, tissue shearing, and 
intraparechymal hemorrhage. The CCI model, which allows better control of the 
biomechanical parameters of injury leading to reproducible injuries, was first introduced 
by Lighthall and colleagues (Lighthall, 1988). The injury is easier to quantify by 
regulation of the impact force, velocity and dwell time and to measure the tissue 
deformation and functional impairment. In the CCI model, a cylinder is used with a round 
or flat edge, and is pneumatically driven to produce injury. Like the FP injury, the CCI 
model also produces injury that resembles certain aspects of human TBI, but it produces 
a significantly more pronounced cortical contusion. Another injury model is the weight 
drop model, which can be used with either an open or closed skull. Injury with an open 
skull produces a focal lesion that progresses from hemorrhages in the white matter to a 
necrotic cavity. A closed skull injury produces a diffuse injury without noticeable 
contusions or hippocampal cell loss. In this model, a weight is released through a guide 
tube and subsequently strikes a footplate resting directly on the exposed brain or directly 
on a cemented disk on the skull. The severity of injury is controlled by the weight and 
distance the weight travels. 
1.4 Current Understanding of Mechanism of TBI 
 TBI is a result of direct and indirect brain damage, resulting from primary 
mechanical injury and secondary injury. Primary mechanical injury can be reduced or 
avoided through protective measures, such as education of potential victims and use of 
safety equipment (helmets, airbags). In TBI, primary mechanical brain injury happens in 
seconds, resulting in subdural hematoma, laceration, diffuse axonal injury, diffuse 
vascular injury, intracerebral hemorrhage, and concussion  (BIROS, 1998a; Armin et al., 
2006). With current technology, it is believed that the brain damage from mechanical 
injury is irreversible. Secondary injury follows primary mechanical injury in minutes, 
hours and days, and is potentially treatable (Hall et al., 2005). 
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Previous studies show secondary injury results in delayed dysfunction and death 
of neuronal populations near and distant to the site of injury. Neuron death resulting from 
secondary injury is complicated, and the pathogenesis is unclear. However, It has been 
shown neuron death involves both cell apoptosis and necrosis (Raghupathi, 2004). There 
are some contributors to the cellular apoptosis and necrosis, including excess excitatory 
amino acids, mitochondrial dysfunction, oxidative damage, and adenosine and 
triphosphate adenine nucleotide depletion, inflammatory events, ion homeostasis 
disruption, proteolytic enzyme activation, DNA damage, and cholinergic receptors 
dysfunction (Simon et al., 1984; Azbill et al., 1997; Sullivan et al., 1998; Tyurin et al., 
2000; Verbois et al., 2002; Mendez et al., 2004; Lu et al., 2005; Cimatti, 2006). This 
dissertation is focused on studies of oxidative damage and mitochondrial dysfunction in 
TBI. 
1.4.1 Mitochondrial Dysfunction in Aging and TBI 
 Mitochondria, believed to have originated from evolution of bacteria having a 
symbiotic relationship with ancient eukaryotic cells, are the power house of eukaryotic 
cells (Margulis, 1981). As the power supply, mitochondria synthesize ATP and consume 
molecular oxygen by reducing O2 to H2O in oxidative phosphorylation. Structurally, 
mitochondria consist of an outer membrane, an inner membrane, the intermembrane 
space and the matrix. However, mitochondria have different shapes and population 
densities in different cells (Figure 1.2) (Perkins and Frey, 2000; Scheffler, 2001). The 
inner membrane folds into cristae to increase the inner membrane area, and is relatively 
rich in protein, consisting of ~ 75% protein and 25% lipids (DePierre and Ernster, 1977). 
One third of mitochondrial proteins, including complexes I, II, III IV and V, adenosine 
triphosphate (ATP) and ion translocators, are involved in the respiratory chain and ATP 
syntheses. The lipids of the inner membrane are predominantly phospholipids, including 
phosphatidylcholine, phosphatidylethanolamine and cardiolipin (Ardail et al., 1990; 
Camici and Corazzi, 1995; de Kroon et al., 1997). The outer membrane contains receptor 
proteins, signaling proteins, and channel proteins, including the Bcl-2 family of proteins, 
hexokinase, and voltage-dependent anion channel (VDAC) proteins (Adams and Cory, 
1998; Verrier et al., 2003; McBride et al., 2006).  The outer membrane is permeable to 
both charged and uncharged molecules with a molecular mass less than 1000 Daltons 
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(Verrier et al., 2003). Ketones, mitochondrial DNA and the enzymes and cofactors 
associated with Krebs cycle, amino acid metabolism and fatty acid oxidation and 
synthesis, and mitochondrial protein folding are located in the matrix. Although 
mitochondria have their own circular DNA, only 13 polypeptides are encoded by 
mitochondrial genes, including seven subunits of complex I, one subunit of complex III, 
three subunits of complex IV, and two subunits of the H+-translocating ATP synthase 
(Scheffler, 2001). There are thousands of mitochondrial proteins encoded by nuclear 
DNA, which are transferred to mitochondria by transporting proteins (Neupert, 1997; 
Pfanner, 1998; Schatz, 1998). 
Mitochondria serve not only as power house, but also as a calcium sink to control 
ion homeostasis through two modes of calcium influx and two of efflux as well as 
through calcium induced formation of the MTP. The most studied Ca2+ influx mechanism 
is the uniporter that transports Ca2+ through its electrochemical gradient without coupling 
the transport to other ions or molecules. Another Ca2+ influx mechanism is the ‘rapid 
mode’ or RAM (Gunter et al., 2000). Calcium efflux pathways include Na+-dependent 
and Na+-independent mechanisms (Crompton et al., 1977; Crompton et al., 1978; 
Murphy and Fiskum, 1988). In addition, mitochondria play a key role in cell signaling, 
regulating cell survival via apoptosis involving Bcl-2 family protein, cytochrome c and 
caspase 9 and 3, and apoptosis-inducing factor (AIF) (Liu et al., 1996; Danial et al., 2003; 
Saelens et al., 2004).  
Glycolysis is an alternative energy production process in cells. Under aerobic conditions, 
glycolysis can produce ATP, NADH and pyruvate. NADH can be transported by the 
glycerol phosphate shuttle or the malate-aspartate shuttle to mitochondria for oxidative 
phosphorylation. Pyruvate is the initial substance in the Krebs cycle for NADH, FADH 
and GTP production. Therefore, glycolysis and mitochondrial oxidative phosphyorylarion 
are closely connected with each other. Hexokinase locates in mitochondrial outer 
membrane and catalyzes ATP-dependent phosphorylation of glucose to form glucose-6-
phosphate, and it is also a key protein in mitochondrial permeability transition pore 
(Robey and Hay, 2006). 
The mitochondrial respiratory chain is the major intracellular source of reactive 
 7
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 oxygen species and free radicals under normal physiologic and pathologic conditions. 
Mitochondria play a key role in aging since they appear to be particularly susceptible to 
damage, as evidenced by dramatic declines in respiratory function, mitochondrial 
transcripts, cytochrome c oxidase activity and ATP production (Calleja et al., 1993; 
Schwarze et al., 1998). Respiratory chain damage, particularly complex I and IV, are 
widely measured to evaluate mitochondrial function (Navarro and Boveris, 2007). Using 
electron microscopy, structurally abnormal mitochondria are observed to accumulate 
during aging (Miquel et al., 1976; Fleming et al., 1985).  The “mitochondrial theory of 
aging” postulates that damage to mitochondrial DNA (mtDNA)  by free radicals leads to 
loss of mitochondrial function and loss of cellular energy (Cortopassi and Wong, 1999). 
Human mtDNA consists of 16,569 base pairs with 37 genes. Unlike nuclear DNA, 
mtDNA has limited protection, and is more easily damaged. In addition, mtDNA repair is 
less efficient than nuclear DNA. Accumulated mtDNA damage could lead to mutations 
and disrupt the mitochondrial protein expression. In addition to damage to mtDNA, free 
radicals can oxidatively damage proteins. For instance, oxidatively damaged aconitase 
and adenine nucleotide transporter (Yan et al., 1997; Yan and Sohal, 1998) have been 
shown to accumulate during aging. In addition, free radicals oxidize unsaturated fatty 
acids and could compromise the integrity of mitochondrial membranes and alter 
permeability. Changes in mitochondrial permeability could lead to structure changes, 
leakage of protons and membrane associated proteins, and reduce mitochondrial 
potential, resulting in compromised the energy production. The reduced mitochondrial 
function and ATP production would decrease the rate of protein synthesis and turnover, 
which in turn could increase protein half-life and the potential for further damage.  
It has been shown that mitochondria play a key role in chronic and acute 
neurodegenerative disorders except aging, including  Parkinson’s disease (PD), AD, 
amyotrophic lateral sclerosis (ALS), ischemic brain injury, and stroke (Kristian and 
Siesjo, 1998). Studies of these diseases show damaged mitochondrial proteins and DNA, 
disrupted signal processing, increased oxidative stress and reduced Ca2+ buffer capacities, 
impairment of respiratory chain function and other enzymes (Xiong et al., 1997b; Fiskum 
et al., 1999; Lifshitz et al., 2004; Chen et al., 2006; Kaddour-Djebbar et al., 2006). 
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Studies of mitochondrial dysfunction in TBI have been limited. The role of 
mitochondria in neuron damage following TBI is unclear. Previous studies show 
metabolic disruption occurs following TBI (Yoshino et al., 1991; Ginsberg et al., 1997) 
as evidenced by reduced capacity to produce glutamine in mitochondria (Ashwal et al., 
2004). The reduced capacity to regenerate glutamine from glutamate in astrocytes could 
lead to excess glutamate in the synaptic cleft, lead to overactivation of ion channels, and 
disrupt ion homeostasis of neurons. In addition, mitochondria show reduced sequestration 
capacity of calcium as early as 3 h post injury (Singh et al., 2006) and provoke cell death. 
C.P. Lee and coworkers (Xiong et al., 1997b), using a controlled cortical impact model, 
also demonstrated considerable impairment of brain mitochondrial respiration following 
injury. Previous research from Hall et al. showed  mitochondrial respiration is damaged 
as early as 30 mins post injury (Singh et al. 2006), and other studies showed respiratory 
damage persisted for up to 14 days following injury (Xiong et al., 1997b). The 
compromised respiration could reduce the ATP production and could significantly affect 
the function of ATP dependent enzymes. Significant ATP shortage could lead to cell 
necrosis. Additionally, contact proteins between the inner membrane, outer membrane 
and intermembrane space form channels called mitochondrial permeability transition 
(MPT) pores and trigger cell death under oxidative stress or excess calcium loading. 
Alterations in mitochondria could trigger free radical leakage and apoptosis through 
cytochrome c release from the mitochondria (Sullivan et al., 2002). Lipid peroxidation 
and mitochondrial protein modifications by reactive oxygen species were shown to be 
significantly increased following severe injury (Singh et al., 2006), and indicate free 
radicals play a role in mitochondrial dysfunction in TBI. In addition, uncoupling proteins 
are shown to play a pivotal role in cell survival and to be interrupted in TBI (Mattiasson 
et al., 2003; Sullivan et al., 2004), and the uncoupling protein inhibitor could reduce the 
mitochondrial damage. Although previous studies show mitochondrial damage in TBI, 
there has been little study of changes in protein expression in mitochondria. are not clear. 
Additionally, the mitochondria are damaged during aging, and respond differently to 
injury in aged animals compared with young animals. The studies described here help 
elucidate the different response of mitochondria in aging and may help explain the 
exacerbated mitochondrial defecits observed in aged patients. 
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1.4.2 Oxidative Stress 
Oxidative stress is a condition in which the balance between antioxidant defenses 
and reactive oxygen species (ROS) generation is disrupted, and favors ROS accumulation 
(Braughler and Hall, 1989). These ROS include superoxide radicals (O2•−), hydrogen 
peroxide (H2O2), hydroxyl radicals (OH.), lipid oxyl or peroxyl radicals (ROO·), singlet 
oxygen, and peroxinitrite (NOOO-), which behave as a unit and are now named “free 
radicals”(Valko et al., 2007). The original oxidative species in vivo is partly reduced 
superoxide (O2·−) and nitric oxide (NO). Free radical species contain unpaired electrons 
in their atoms, and are very chemically reactive.  
Mitochondria are the major source of superoxide radicals, although other enzymes 
such as xanthine oxidase and NADH peroxidase are also contributors (Antoine et al., 
2006; Valko et al., 2007). It is estimated that 70-80% of O2·− from mitochondria is 
vectorially released to mitochondrial matrix and 20-30% to the intermembrane space 
(Navarro and Boveris, 2007). The two major O2·− production reactions have been 
described as auto-oxidation of intermediate semiquinones: UQH· for the 
ubiquinone/ubiquione redox pair (UQH· + O2 →UQ + H+ + O2·−) (Boveris and Chance, 
1973) and the FMN• of the FMNH2/FMN coenzyme of NADH dehydrogenase (FMNH• + 
O2 → FMN + H+ + O2·−) (Turrens and Boveris, 1980).  The reactions are 
nonenzymatically oxidized by molecular oxygen to yield superoxide.  
Iron is one of the most abundant metal ions in humans. Iron is a late transition 
metal and has two oxidation states (+2 and +3). Fe2+ is a reducing reagent and Fe3+ is an 
oxidizing agent Iron is generally incorporated into the heme complex. In most organism, 
heme is an essential component of cytochrome proteins, which mediate redox reactions, 
and of oxygen carrier proteins such as hemoglobin and myoglobin. Iron toxicity occurs 
when there is free iron in the cell, which generally occurs when iron levels exceed the 
capacity of transferrin to bind the iron. Iron is involved in ROS production of superoxide, 
and hydroxyl radicals by Fenton’s reaction (Figure 1.3) (Braughler et al., 1986), in which 
Fe2+ is oxidized to Fe3+, and H2O2 is reduced and decomposed to form hydroxyl radical. 
Fe3+ can be reduced by superoxide to regenerate Fe2+. Free radical damage is a major 
theory of aging and neurodegenerative diseases. This theory of aging postulated by 
Denham Herman suggested that free radical damage and the accumulation of the  
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Fe(III) + Reductant Fe(II) + oxidant
Fe(II) + O2 Fe(III) + O2
.-
2O2
.-
+   2H+ H2O2  +  O2
Fe(II)  +  H2O2 Fe(III)  +  OH -  +  OH. Fenton's reaction
superoxide dismutation
 
 
Figure 1.3. Iron is the most abundant transition metal ion in brain, and is derived from 
hemoglobin or transfer protein release. Increased iron exposure leads to increased 
oxidative damage. The most important reaction in the formation of OH• is the Fenton’s 
reaction, which was established in 1894. 
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oxidative damage is the cause of cell death, organ dysfunction and aging (Harman, 1972). 
It is suggested the ability of cells to detoxify ROS and replace oxidatively damaged 
macromolecules is apparently inefficient over time, as oxidative damage products 
accumulate in every aging organism examined. Previous studies show significantly 
increased superoxide in brain in aging, and superoxide levels in hippocampus are higher 
than in cortex or striatum (Antier et al., 2004). Superoxide and other free radicals with 
unpaired electrons can damage polyunsaturated fatty acids (arachidonic acid and 
decosohexaenic acid), DNA and proteins, resulting in formation of toxic aldehydic 
products (Figure 1.4) and oxidized DNA bases, protein thiol loss, protein cross linking, 
protein and DNA cross linking, and protein or DNA adducts with aldehyde products of 
lipid peroxidation (Braughler and Hall, 1989). As the major source of ROS, mitochondria 
appear to be also a key target of oxidative damage during aging (Nicholls, 2002; 
Lesnefsky and Hoppel, 2003). Previous studies show increased lipid peroxidation 
products, DNA oxidation products and abnormal proteins in aging (Sohal et al., 1995; 
Schwarze et al., 1998; Orr et al., 2003), and that mitochondrial DNA are more severely 
oxidatively damaged than nuclear DNA (Wang et al., 2003).  
Lipid peroxidation products are stable markers of membrane lipid damage and 
oxidative stress. Studies of lipid oxidation can be traced back to the 1940’s when it was 
shown that hydroperoxides are the primary products of hydrocarbon oxidation (Farmer et 
al., 1942). Detailed studies of products of polyunsaturated fatty acid oxidation were 
initiated in the 70's, and the first demonstration of free radical oxidation of membrane 
phospholipids was in 1980 (Porter et al., 1980a, b). Many lipid peroxidation products 
have been identified, including primary products such as F2-isoprostanes and 
hydroperoxides of oleic acid, linoleic acid, and other highly unsaturated fatty acids like 
arachidonic acid. These primary products could be oxidized to secondary products, such 
as 4-hydroxy-2-nonenal (Schneider et al., 2001), 4-hydroxy-2,3–hexenal, acrolein, and 
malondialdehyde (MDA). Previous studies show increased lipid peroxidation following 
TBI, including significant elevations of thiobarbituric acid reactive substances (TBARS) 
and 8-isoprostaglandin F2α in injured cortex (Hoffman et al., 1996; Hsiang et al., 1997). 
Recently, 4-hydroxynonenal (HNE) and acrolein, two neurotoxic byproducts of lipid 
peroxidation of arachidonic acid (Benedetti et al., 1980), have become of interest in a 
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variety of neurological diseases (Lovell et al., 1997; Lovell et al., 2000). HNE levels 
were shown to be significantly increased in brain and spinal cord injury (Baldwin et al., 
1998; Zhang et al., 1999; Cao et al., 2001; Hall et al., 2004; Singh et al., 2006) in young 
animals, although the lipid peroxidation in TBI in aging remains unclear. 
  HNE and acrolein are most toxic byproducts of lipid peroxidation. It is well 
established that HNE and acrolein can modify proteins, DNA/RNA in vivo and in vitro, 
and these modifications could lead to protein dysfunction (Hiratsuka et al., 2000; 
Akagawa et al., 2006). Previous studies show HNE modification can lead to dysfunction 
of oxidative phosphorylation complexes, Na+/K+-ATPase, NADP+-dependent isocitrate 
dehydrogenase, proteasome, and cathepsin B (Siems et al., 1996; Okada et al., 1999; 
Crabb et al., 2002). In addition, HNE can improve AP-1 binding activity (Camandola et 
al., 2000) and trigger apoptosis (Bruckner et al., 2003), leading to neuron death and tissue 
loss in injured animals. Additionally, HNE can trigger an epidermal growth factor 
receptor-linked signal pathway for growth inhibition by phosphorylation of adaptor 
protein Shc and activation of MAP kinase (Liu et al., 1999). It has also been shown that 
HNE  can induce the heat shock protein factor and upregulate the heat shock protein 
expression in cell culture (Cajone, 1988), triggering cell defense. A small number of 
studies show lipid peroxidation increases immediately after TBI and is maintained for 
several days (Hall et al., 2004). 
When ROS are produced close to DNA, it can result in DNA damage. It is 
suggested that hydroxyl radicals generated from hydrogen peroxide are extremely active 
with a life time of ~10-6 s, and can react close to its formation (Pastor et al., 2000). DNA 
oxidation includes damage to base and sugar moieties, leading to DNA strand breaks, 
gene mutation and cell apoptosis (Chen et al., 1997; Johnson et al., 2005). Currently, 
about 20 DNA base oxidative products have been identified. For example, oxidized 
guanine in DNA by reactive oxygen species leads to formation of 7,8-dihydro-8-
oxoguanine (8-OHG), and ring opening products 2,6-diamino-4-hydroxy-5-
formamidopyrimidine (fapyguanine, FG). Adenine oxidative products include 8-
hydroxyadenine (8-OHA) and 4,6-diamino-5-formamidopyrimidine (fapyadenine, FA). 
For cytosine and thymine, oxidative damage results in formation of 5-hydroxycytosine 
(5-OHC), 5,6-dihydroxycytosine, 5-hydroxy-6-hydrothymine and thymine glycol. The 
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DNA base oxidative products can be used as markers to evaluate the oxidative damage in 
cell. The effect of oxidative stress in DNA damage has been studied extensively in aging, 
cancer, AD, HD, diabetes and stroke, but limited in TBI (Alam et al., 1997; Rehman et 
al., 1999; Nagayama et al., 2000; Wang et al., 2005). The accumulation of free radical 
induced damage to DNA is illustrated by an age-related increase in human serum over an 
age range of 15-91 years (Valko et al., 2007). Numerous studies have reported the 
accumulation of 8-OHG and other lesions with age, both in vivo and in vitro, in nuclear 
and mitochondrial DNA. Although 8-OHG levels are increased in injured brain cortex in 
TBI in young animals(Mendez et al., 2004), it is unclear whether DNA oxidative damage 
is exacerbated in TBI in aging.  In order to evaluate DNA oxidative damage in TBI in 
aging, 8-OHG, FG, 8-OHA, FA, and 5-OHC are oxidized bases investigated in this 
dissertation (Figure 1.5). 
1.4.2.1 Mechanism of Lipid Peroxidation 
Unsaturated fatty acids, especially ω-3 such as linoleic acid, and ω-6, including 
arachidonic (AA, 20:4n-6), docosatetraenoic acid (DCS, 22:4n-6) and decosohexaenic 
acid (DCH, 22:6n-6), are major components of cell membranes and organelles. These ω-
6 fatty acids are abundant in brains and highly susceptible to free radical attack. Lipid 
peroxidation forms a variety of products, including malondialdehyde, 4-hydroxynonenal, 
acrolein, and other aldehydes (Williams et al., 2005). The mechanism of lipid 
peroxidation in vivo is difficult to investigate because of the complicated cellular 
environment. However, studies in organic chemistry help suggest possible pathways of 
lipid peroxidation. Using arachidonic acid and linoleic acid as substrates, their 
autoxidation and enzyme catalyzed oxidations were investigated. Arachidonic acid or 
linoleic acid may be attacked by free radicals and lose hydrogens attached to bis- allylic 
carbons (Thomas and Pryor, 1980). Oxygen can then add to allyl radicals and form 
peroxyl radicals. The peroxyl radical may abstract hydrogen from hydrogen donor 
forming hydroperoxide. Hydroperoxides are precursors of products such as 4-HNE and 
acrolein (Porter et al., 1981). In arachidonic acid autoxidation, six major conjugated diene 
hydroperoxide, hydroperoxyeicosatetraenoic acids (HPETE), have been identified (Porter 
et al., 1979), and all have trans,cis conjugated diene stereochemistry 
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Figure 1.5. DNA base oxidation products investigated in this dissertation. 
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with hydroperoxide substitution being at carbon 5, 8, 9, 11, 12, or 15. Further 
oxygenation can form dihydroperoxides, which fragment to 4-hydroperoxy-nonenal by 
Hock rearrangement.  4-Hydroperoxy-nonenal could form 4-hydroxynonenal (Figure 
1.6). The mechanism for acrolein formation from unsaturated fatty acids is not well 
investigated yet. It’s possible the formation of acrolein follows a different mechanism. 
 1.4.2.2 Mechanism of DNA Oxidation 
 Free radicals attack of the DNA strand leads to DNA base and ribose moiety 
oxidation. The attack of ribose could lead to strand break and DNA fragmentation. 
Damage to DNA bases could result in a variety of base oxidation products. However, 
radicals have a high preference for interaction with the base part of the molecule rather 
than with the ribose (phosphate) (O'Neill and Davies, 1987). The addition of OH• to 
purines could form C4-OH, C5-OH, and C8-OH products. The C8-OH adducts of purines 
could form 8-OHG, FG, 8-OHA, and FA products (Figure 1.7). As for pyrimidine base, 
hydroxyl radical (OH·) could attack C5 and C6 to from cytosine glycol, which dehydrates 
to form 5-OHC (Figure 1.8). Among the bases, guanine is the most easily oxidized, 
which is supported by MO calculation, ionization potential, and aqueous-phase redox 
(Jovanovic and Simic, 1986; Steenken, 1989). 
1.5 Antioxidant Enzymes 
 Exposure to free radicals from a variety of sources has led to development of a 
series of defense mechanisms. Defense mechanisms against free radical-induced 
oxidative stress include: preventive mechanisms, repair mechanisms, physical defenses, 
and antioxidant defenses. Non-enzymatic antioxidants incude ascorbic acid (Vitamine C), 
alpha-tocopherol (Vitamine E), glutathione (GSH), carotenoids, flavonoids, and other 
antioxidants. Antioxidant enzymes include superoxide dismutase (Cu/ZnSOD and 
MnSOD), catalase and glutathione peroxidase (GPx), glutathione reductase (GSSG-R), 
and glutathione transferase. These enzymes work in concert to protect cells (Figure 1.9). 
1.5.1 Superoxide Dismutase (SOD)  
 SOD, a metalloenzyme was first discovered by McCord and Fridovich (McCord 
and Fridovich, 1969). SOD catalyzes the dismutation of toxic superoxide radicals with 
the conversion of hydrogen ions to hydrogen peroxide, which is less toxic. It has been 
established that all organisms living in the presence of oxygen have at least one form of 
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Figure 1.6. Mechanism of arachidonic acid autoxidation lipid peroxidation generates 
HNE. R• represents free radical. 
COOH
O2
R
RH
RH
RH
.
.
.
.
R
Hock rearrangement
O2RH
H2O
OOH
O
Arachidonic acid
HNPE
O.
O
OH.
RH
OH
O
HNE
COOH.
COOH
.
COOH
HOO
H
COOH
HOO
COOH
HOO
COOHO
HOO
COOH
HOO HOO
COOH
O
 
 19
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7. Mechanism of 8-hydroxyguanine, fapyguanine, 8-hydroxyadenine, and 
fapyadenine formation. R=H. 
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Figure 1.8. Mechanism of 8-hydroxycytosine formation.
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Figure 1.9. Antioxidant enzymes. 
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SOD, with an active site containing manganese, iron, nickel or copper-zinc (Cadelli et al., 
1999; Niviere and Fontecave, 2004). Manganese (Mn) and copper-zinc (Cu/Zn) 
dismutases are present in human and animals. MnSOD (MW 26.6 KDa) is located in 
mitochondrial matrix, and Cu/ZnSOD (32 KDa) is found in cytosol, mitochondrial 
intermembrane space and extracelluar fluid. The gene encoding SOD human mRNA 
resides on chromosome 21.  
 SOD plays a key role in antioxidant defense. Cu/ZnSOD activity decreased in 
stroke, SOD protein and gene transcription levels, and the enzyme activity are 
investigated have been widely investigated in a variety of neurodegenerative diseases, 
including ALS, AD, PH, spinal and brain injury (Trotti et al., 1999; Demirkaya et al., 
2001; Earnhardt et al., 2002; Antier et al., 2004; Vaziri et al., 2004). Transgenic animals 
with increased expression of SOD show increased life span and less damage following 
ischemic injury (Saito et al., 2003). SOD mimetics were reported to be effective in 
attenuating oxidative associated neurodegenerative disease.  
1.5.2 Glutathione Peroxidase and Catalase 
 As mentioned above, superoxide dismutase catalyzes the dismutation of 
superoxide radical (O2•−) to produce hydrogen peroxide (H2O2), a quite stable and 
invasive ROS. Moreover, through the Fenton and Haber-Weiss coupled reactions, H2O2 
forms reactive hydroxyl radical (OH•). To efficiently remove hydrogen peroxide, two 
antioxidant enzymes are available: catalase and GPx, which both transform H2O2 into a 
harmless product, H2O. These two enzymes do not work in identical conditions although 
they do similar jobs. First, catalase only uses H2O2 as a substrate, whereas GPx uses both 
H2O2 and lipid peroxides as substrates (Cohen and Hochstein, 1963).  Catalase functions 
when H2O2 concentrations are significantly above physiological levels that can occur in 
oxidative bursts characteristic of stress responses. However, GPx functions during small 
variations of H2O2 concentrations (Drevet, 2006). Therefore, GPx activity represents the 
first protective response for small adjustments in H2O2 concentrations under normal 
physiological conditions. Glutathione peroxidase also needs glutathione as a substrate, in 
which reduced glutathione (GSH) is converted to oxidized form (GSSG).  
 Glutathione peroxidase is a family of proteins, divided into five classes (GPx1 to 
GPx5) (Chu, 1994) based on their primary sequence, substrate specificity and subcellular 
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localization. GPX1, the so-called cytosolic or cellular GPx, was the first GPx to be 
discovered (Mills, 1957), and is abundant in kidney, lung, red cells and liver, but 
relatively low in brain. GPx2, another cytoplasmic enzyme, exists in stomach and 
intestines (Chu et al., 1993).   GPx3, an extracellular GPx or plasma-type GPx (pGPx), 
was found to be preferentially expressed in the mammalian kidney with lower levels in a 
wide array of tissues (Maser et al., 1994; Schwaab et al., 1998). GPx4, also called 
phospholipid hydroperoxide glutathione peroxidase (PHGPx), is a membrane-associated 
GPx expressed in the mammalian testis, brain and heart (Ursini et al., 1982). GPX5, also 
previously known as MEP24 (for mouse epididymal protein of 24 KDa) or epididymal 
GPX (epGPx), is a highly restricted GPx and is expressed only in the mammalian caput 
epididymidis (Ghyselinck and Dufaure, 1990). In higher animals, GPxs are selenium-
containing proteins. They contain a selenocysteine residue, which form so-called catalytic 
triad with glutamine and tryptophan residues (Maiorino et al., 1995). 
1.5.3 Glutathione Reductase 
 Glutathione, a triamino acid peptide (γ-glutamylcysteinylglycine), is an 
antioxidant molecule, and also functions in DNA and protein synthesis regulation, signal 
transduction, cell-cycle control, proteolysis, immune response and cytokine synthesis 
(Harding et al., 1996; Wu et al., 2004). The synthesis of GSH is catalyzed by γ-
glutamylcysteine synthetase (GCS) and GSH synthetase. GCS activity, cysteine 
availability, and GSH feedback inhibition are the main factors regulating GSH synthesis. 
In addition, recycling of oxidized GSH produced by GPx is important in the maintenance 
of reduced GSH levels in the cell. Glutathione reductase is the enzyme that converts 
oxidized GSH (GSSG) back to reduced GSH, and is involved in the pathogenesis of 
many diseases. The conversion from GSSG to GSH requires NADPH, which is produced 
from reactions catalyzed by glucose-6-phosphate dehydrogenase and 6-phosphogluconate 
dehydrogenase. GSSR-R is important not only for maintaining the required GSH level 
but also for reducing protein thiols to their native state (Ganea and Harding, 2006). 
1.5.4 Glutathione Transferase  
Glutathione transferase (GST) is a family of detoxification enzymes that catalyze 
the conjugation of glutathione (GSH) to a wide variety of xenobiotics (McIlwain et al., 
2006). GST isoforms contain a highly conserved N-terminal domain which has a 
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catalytically active tyrosine, cysteine or serine residue. The catalytic residue interacts 
with the thiol group of GSH (G-site), and the substrate binding site (H-site) near the G-
site to facilitate catalysis (Dirr et al., 1994; Armstrong, 1997). The detoxification ability 
of GST plays a role in cellular protection from environmental and oxidative stress. 
Human GSTs are divided into three main families: cytosolic, mitochondrial and 
membrane-bound microsomal.  
1.5.5 Antioxidant Capacity in Aging and Neurodegenerative Diseases 
 Aging is correlated with a reduced redox state and diminished antioxidant 
capacities. Reducing equivalents, especially glutathione, are involved in maintaining 
redox balance throught the cell. Reduced antioxidant defenses could change the redox 
condition of cells. Many proteins contain redox-sensitive regulatory amino acid residues. 
The reduced levels of glutathione could lead to the inactivity of redox sensitive proteins 
(Kim et al., 2002; Droge, 2003). Aging studies using mice showed a 40% increase in 
median life span and a 17% increase of maximal life span with supplementation with 
Vitamine E (Navarro et al., 2005). Studies of Cu/ZnSOD show increased activity as a 
function of age in brain, although other studies show the Cu/ZnSOD decreased in cortex, 
hippocampus, and striatum in aged animals compared with young animals, which could 
contribute to the increase of superoxide in aging (Antier et al., 2004). Additionally, 
studies show no significant changes of Cu/ZnSOD and catalase levels among age groups 
of 35-39, 50-54, and 65-69 years (Barnett and King, 1995). Because of the ability to 
convert very active superoxide to less active hydrogen peroxides Cu/ZnSOD can reduce 
the damage to DNA, RNA, protein, and unsaturated fatty acids. However, SOD defense 
appears unable to keep pace with endogenous and exogenous sources of damage even 
though antioxidant enzyme levels are unchanged or increased, leading to progressive 
deterioration of structure and function with age. In neurodegenerative disease, 
Cu/ZnSOD mutantions lead to oxidative damage, and associated with diseases such as 
ALS (Trotti et al., 1999). MnSOD, a mitochondrial SOD, reduces the potential damage to 
mitochondrial proteins and mtDNA. MnSOD expression is down regulated in smooth 
muscle cells (Li et al., 2006), and human granulosa cells (Tatone et al., 2006), and could 
contribute to their dysfunction in aging. In brain, MnSOD activity decreases linearly 
upon aging (Navarro et al., 2002). It has been shown that partial MnSOD deficiency (+/-) 
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results in mice with increased mitochondrial damage during aging (Wallace, 2002). 
However, other studies indicate no significant changes in brain in aging (Antier et al., 
2004). 
 In AD, elevated SOD, catalase, GPx and GSSG-R and decreased GST activities 
were reported, indicating a compensationary response in disease for most antioxidant 
enzymes (Lovell et al., 1995; Lovell et al., 1998). In spinal cord injury, Azbill et al. 
showed SOD was unchanged following injury (Azbill et al., 1997). In TBI, Dekosky et 
al. showed SOD activity decreased, GPx and catalase increased significantly following 
injury in young animals (DeKosky et al., 2004). However, the response of antioxidant 
enzymes has not been investigated in TBI in aging.  
1.6 Measurement of Oxidative Damage 
Oxidative damage is widely investigated in a variety of diseases, including 
cancer, AD, HD, diabetes, ALS, aging, stroke, cardiovascular disease, and TBI. There are 
several methods to evaluate oxidative stress in vivo and in vitro, including measurement 
of the reducing capacity of tissue or cell (Shohami et al., 1999); trapping the superoxide 
radicals using electron spin resonance trapping reagents (Awasthi et al., 1997); measuring 
products of oxidative stress such as lipid peroxidation (Hsiang et al., 1997) and DNA 
oxidation (Mendez et al., 2004) or protein modification (Chirino et al., 2006). Measuring 
lipid peroxidation byproducts, DNA oxidation markers, and protein carbonyls are 
currently the most commonly used methods. 
1.6.1 Analysis of By-products of Lipid Peroxidation  
The measurement of markers of lipid peroxidation can be carried out using 
fluorescence spectrometry, chromatography, and immunochemistry (Awasthi et al., 1997; 
Hsiang et al., 1997; Lovell et al., 1997; Lovell et al., 2000; Hall et al., 2004; Davis et al., 
2006). Immunochemistry methods include Western blot, dot blot, slot blot and tissue 
section staining. Immunochemistry measures the protein-bound lipid peroxidation 
byproducts, which look at the protein modifications under oxidative stress (Springer et 
al., 1997). Chromatography and fluorescence spectrometry methods quantify the free or 
unstable protein-bonded lipid peroxidation byproducts in vivo. For example, using 
fluorescence method, MDA, HNE and acrolein can be measured following derivatization 
(Ohkawa et al., 1979; Lovell et al., 1997; Lovell et al., 2001).  
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1.6.2 DNA Oxidation Analysis 
DNA oxidative damage is widely investigated as a major marker of oxidative 
damage in a variety of diseases (Loft and Poulsen, 1996; Kowalczyk et al., 2004; Mendez 
et al., 2004). Various chemical and biochemical methods have been proposed, including 
indirect measurements based on the use of antibodies (Mendez et al., 2004), single-cell 
gel electrophoresis (Collins et al., 1995), 32P-postlabeling assays (Cadet et al., 1992), and 
direct analysis by HPLC (Kasai, 1997) and GC/MS (Dizdaroglu and Bergtold, 1986). The 
direct approach involves isolation of DNA, followed by hydrolysis for nucleosides or 
nucleobases of DNA sample. The indirect methods are usually highly sensitive, but their 
specificity is still open to debate. High performance liquid chromatography associated 
with electrochemical detection (HPLC-EC) and gas chromatography coupled to mass 
spectrometry (GC/MS) have been the most widely applied methods during the last decade 
with detection limit of 50 fmol of oxidized base, which corresponds to one lesion per 106 
normal base or in a DNA sample size of 10 pg. HPLC-EC assays are aimed at monitoring 
the formation of oxidized bases with a low oxidation potential. The assay was initially 
developed for the measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-OHG) (Floyd 
et al., 1986), and then extended to 8-oxo-7,8-dihydro-2'-deoxyadenosine (8-OHA) 
(Berger et al., 1990), 5-hydroxy-2'-deoxycytidine and 5-hydroxy-2'-deoxyuridine, 5-
hydroxy-2'-deoxyuridine, and 5-hydroxy-2'-deoxycytidine (Wagner et al., 1992).  
However, one limitation of HPLC-EC deals with the fact that only bases with a 
low oxidation potential can be measured by electrochemical detection. In contrast, 
GC/MS is a more versatile technique since it is less dependent on the chemical properties 
of the oxidized base of interest (Dizdaroglu, 1991). The mass spectrometer may be set in 
the selective ion monitoring (SIM) mode that detects only the ions corresponding to the 
major peaks of the mass spectrum of the bases, which provides a more specific and 
sensitive detection. One point that should be noted is the bases have to be derivatized into 
volatile compounds prior to their injection into the GC/MS. In the current method, staple 
isotopically enriched internal standards, which differ from the oxidized DNA bases in 
samples by three units of mass, are used. Internal standards could reduce errors from the 
derivatization step and also compensate for the possible lack of reproducibility of the 
injection. The GC/MS assay was first applied to the detection of 8-OHG in isolated DNA 
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that was exposed to γ-radiation in aqueous solution (Dizdaroglu, 1985). Subsequently, the 
method has been applied numerous times to the measurement of many types of oxidative 
base damage in isolated DNA (Aruoma et al., 1989; Spencer et al., 1994; Fuciarelli et al., 
1995; Wang et al., 2005) and within isolated cells (Djuric et al., 1991). 
1.6.3 Protein Carbonyl Modification and Nitration Analysis  
 Under oxidative stress, proteins are targets of reactive oxygen species and lipid 
peroxidation byproducts. Modification of thiol group on amino acid side chains can  
result in loss of protein folding and incorrect folding (de Venevelles et al., 2006). 
Aldehydic products of lipid peroxidation can react with amine groups to form Shiff base 
adducts or react with cysteine to form Michael addition products (Hashimoto et al., 
2003). The peroxynitrite can modify tyrosine to inactivate proteins (Chirino et al., 2006; 
Tao et al., 2006). Protein carbonyl and nitration can be measured using 
immunochemistry, immunohistochemistry and mass spectrometry (Hall et al., 2004; 
Matters et al., 2006). 
1.7 Proteomics 
Currently, biologists try to understand the function of cell at the molecular level 
and to look for biological markers in cells with disease. Over the past several decades, 
considerative effort has been directed at the polynucleotide level. Complete sequencing 
of genome in a wide variety of simple organisms and great progress in the human 
genome project provide the chance for the development of research at the protein level. 
The expected proteins in human may be as many as millions if splice variants and post 
translation modifications are considered (Wilkins et al., 1996; Binz et al., 1999; Wilkins 
et al., 1999). Based on genome and protein databases such as SwissProt and NCBI 
thousands of proteins are predicted. The complete set of proteins that result from a 
genome is called the proteome (Wasinger et al., 1995), which is dynamic and highly 
dependent on the type of cell and its state. The development of Mass Spectrometry tools, 
such as the Matrix Assisted Laser Desorption Ionization (MALDI) and electrospray 
ionization, provides effective tools to investigate protein levels in cell. Proteomics is a 
method to display and detect all cellular proteins, and study multiple gene/protein 
functions and networks (Schilling et al., 1999).  
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1.7.1 Two Dimensional Gel Proteomics 
In current proteomic studies, protein separation before identification is critical. 
The separation of a complicated protein mixture from cells was firstly achieved more 
than 30 years ago using two dimensional polyacrylamide gel electrophoresis (2D PAGE) 
(O'Farrell, 1975). In this method, proteins are separated by their isoelectric point in one 
dimension and molecular weight in the second dimension. In the first dimension, proteins 
are loaded onto immobilized pH gradient strips, and separated under high voltage from 
hundreds to thousands volts. The secondary dimension is similar to running a 1D gel. The 
proteins in the 2D page are visualized by Coomassie blue staining, silver staining, or by 
Sypro ruby staining and imaged by fluorescence scanning. Protein spots of interest are 
cut out, and proteolytically digested to release peptides. Peptides from in-gel digestion 
are loaded onto matrix for MALDI MS and the peptide can be sequenced by mass 
spectrum fingerprint and then identified based on comparision to a database. It is 
predicted that up to 5000 proteins can be displayed by this method, and post-translational 
modifications and single-site mutations can be detected with proteins differing in 
concentration by ratio of 10-4 to 10-5 detected.  
Two dimensional PAGE proteomics has allowed many proteins in different 
organisms or animal and human tissues to be mapped, but this method is labor intensive 
and difficult to match protein spots on various gels. In addition, less abundant proteins, 
proteins with low or high molecular weight as well as proteins with acidic or basic side 
chains are difficult to detect. Additionally, membrane protein analysis is also difficult 
using this method (Godovac-Zimmermann and Brown, 2001).  
1.7.2 Isotope-coded Affinity Tag Proteomics 
To overcome problems associated with 2D PAGE, Isotope-coded Affinity Tag 
(ICAT) was developed by Gygi et al., and uses heavy and light reagents to label control 
and treatment samples separately (Gygi et al., 1999). This gel free method allows more 
automatic protein analysis. In this method, cysteine residues in amino acids are labeled 
by a tag, which contains a biotin moiety for subsequent isolation of the labeled peptides. 
Rather than displaying the cellular proteins by 2D PAGE, the cellular protein mixtures 
are subjected to tryptic digestion after labeling, and the Cys-containing peptides isolated 
by chromatography on an avidin column. Purified Cys-containing labeledpeptides are 
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separated by 2D microcapillary liquid chromatography and ionized by electrospray 
ionization, and identified by 2D LC-MS/MS. The ICAT proteomics method requires 
much less sample for analysis compared with 2D PAGE, which is useful for studies of 
subcellular organelle or where limited material is available.  The heavy and light labeling 
reagents differ in mass since they have different isotopes, and this mass difference help 
MS determine if the peptide is from control or treatment sample. So far, ICAT reagents 
have been labeled with deuterium or 13C, and the mass difference between heavy and 
light can be 8 or 9 Da (Lovell et al., 2005). The peptides are sequenced by mass 
spectrometry and used for database searches to identify proteins based on their peptides.  
1.8 The Effort to Find Efficient Treatment for TBI 
Currently, research on TBI is directed at understanding the mechanisms of neuron 
injury and the search to find an effective therapy for clinical application. Based on the 
understanding of the injury, some treatment methods such as hypothermia (Davies, 2005) 
and many kinds of drugs have been proposed. Current drugs under investigation include: 
inhibitors or regulators targeting specific proteins such as lithium (Wada et al., 2005), 
magnesium (Enomoto et al., 2005; Ghabriel et al., 2006), N-(4-fluorophenylsulfonyl)-L-
valyl-L-Lleucinal (Inoue et al., 2003), cyclosporine A (Rabchevsky et al., 2001), 
progesterone (Fiskum G, 2006, p235), dexanabinol, and dexamethasone; antioxidants 
such as metalloporphyrin (Tauskela et al., 2006), bromocriptine (Kline et al., 2004) and 
N-acetylcysteine (Yi et al., 2006), and protective drugs with unknown mechanisms such 
as methylprednisolone (Rabchevsky et al., 2002).  
Creatine has been shown to increase lean body mass, muscular strength, and 
sprint power, and is one potentially protective compound of interest in TBI (Matthews et 
al., 1999; Sullivan et al., 2000). Creatine is an endogenous substance synthesized mostly 
in kidney and liver. Creatine biosynthesis has two sequential steps catalyzed by L-
arginine:glycineamidinotransferase and S-adenosylmethionine:guanidinoacetate N-
methyltransferase (Braissant et al., 2005). Cells with high energy demand can take up 
creatine from the blood stream with the involvement of a specific creatine transporter 
(CRT). Imported creatine can be converted to phosphocreatine by creatine kinase with 
consumption of ATP provided through oxidative phosphorylation and glycolysis at 
contact sites of mitochondria or in cytosol (Jacobus, 1985) (Figure 1.10). 
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Phosphocreatine is an energy pool and can be available in cytosol. ATP levels in cytosol 
can be maintained at a stable level with the hydrolysis of phosphocreatine to regenerate 
ATP to satisfy the demand of different biological process, such as ATPase and other 
ATP-regulated process, which contribute to the protective function of creatine. It was 
shown that creatine can regulate the mitochondrial transition pore by stimulating creatine 
kinase located in the intermembrane space of mitochondria (O'Gorman et al., 1997). 
Creatine supplemented animals maintained better calcium buffering capacity compared to 
animals without suppleentation following brain injury (Sullivan et al., 2000). Studies also 
show that creatine can function as an antioxidant in vitro, showing a significant ability to 
remove superoxide and peroxynitrite (Lawler et al., 2002). 
Oral supplementation of creatine (Cr) has recently been shown to be protective in 
a variety of neurodegenerative diseases, including HD, PD, ALS, and TBI (Klivenyi et 
al., 1999; Matthews et al., 1999; Ferrante et al., 2000; Sullivan et al., 2000). In animal 
models of ischemia, creatine supplementation resulted in neuroprotection and a 
remarkable reduction in ischemic brain infarction. Caspase-3 activation and cytochrome c 
release were significantly reduced, and ATP levels were maintained (Zhu et al., 2004). 
Despite its well documented neuroprotective properties and its possible mechanism, 
creatine’s protective role in TBI is not well understood. 
1.9 Experiment Design 
Because secondary injury is the only possible curable damage so far in TBI we 
decide to investigate the factors in secondary injury to find a clue for clinical therapy. As 
mentioned ealier in the desertation that oxidative damage and mitochondrial dysfunction 
play key roles in TBI. In order to understand the effect of age on TBI, this dissertation 
was to investigate the oxidative damage in TBI in aging, and to elucidate the exacerbated 
injury in TBI in aging. In our study, young (3 months), middle aged (12 months) and 
aged (22 months) animals were investigated using a controlled cortical impact injury. To 
evaluate mitochondrial dysfunction, mitochondria were isolated following TBI and 
subjected to proteomics. To test potential therapeutics to prevent against secondary 
injury, oxidative damage in creatine supplemented animals was measured. 
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Figure  1.10. Creatine phosphorylation.
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1.9.1 Oxidative Stress in TBI in Aging 
 As mentioned earlier, aging is an important factor in brain injury, and aged 
patients are more likely to sustain more severe injury than young adult patients. The 
reason for this phenomenon is not well understood. Previous studies show oxidative 
stress could be a factor for many pathological processes, but has not been investigated in 
head trauma in aging. In the current project, Fisher-344 rats were subjected to CCI, and 
HNE and acrolein, toxic markers of lipid peroxidation, evaluated using immunochemistry 
(dot-blot) at 1 and 7 days post injury. Further studies were performed to determine 
antioxidant defense capacities of animals in head trauma in aging. The antioxidant 
enzyme activities, including MnSOD, Cu/ZnSOD, GPx, GSSG-R, and GST, were 
investigated. 
DNA oxidation may contribute to gene mutation or protein expression changes, 
and is widely used as a marker for oxidative damage. To determine if the oxidative stress 
in TBI in aging impacts DNA, 8-OHG, FG, 8-OHA, FA, and 5-OHC were investigated in 
injured rat brains using GC/MS-SIM. Stable isotope labeled oxidized DNA bases labeled 
with 15N and 13C were used as internal standards for quantification. 
1.9.2 Protection by Creatine in TBI  
 Creatine has been shown to be neuroprotective in neurodegenerative 
disorders. In order to investigate the effect of creatine on TBI, Sprague-Dawley rats with 
1% and 2% creatine supplementation were subjected to CCI, sacrificed at 24 h post 
injury, and HNE and acrolein levels in cortex and hippocampus measured using dot-blot 
immunochemistry. Additionally, enzyme activities, including MnSOD, Cu/ZnSOD, GPx, 
GSSG-R, and GST, were investigated. 
1.9.3 Mitochondrial Proteomics 
Previous studies showed oxidative damage, ion homeostasis disruption, and ATP 
depletion following TBI. Mitochondria play a key role in these pathologies and regulate 
the fate of neurons in TBI. Mitochondrial dysfunction is also the reason of aging. 
Although studies showed that mitochondrial swelling, mitochondrial membrane 
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permeability changes, reduced amount of isolated mitochondria, respiration chain 
damage in TBI, the individual mitochondrial protein expression level is not evaluated. In 
this dissertation, young Fisher-344 rats were subjected to CCI and the mitochondria were 
isolated at 1 and 24 h post injury. Mitochondrial protein expression was quantified using 
isotope-coded affinity tag (ICAT) labeling and 2D-LC/MS/MS. In the further, we will 
use middle aged and aged animals to evaluate mitochondrial dysfunction in TBI in aging. 
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Chapter Two 
Materials and methods 
2.1 Materials 
Stable isotope labeled oxidized bases were obtained from Cambridge Isotope 
laboratories (Andover, MA, USA), and included 8-[8-13C,7,9-15N2] hydroxyguanine, 
[formyl-13C, diamino-15N2] fapyguanine, 8-[8-13C,6,9-diamino-15N2] hydroxyadenine, 
[formyl-13C, iamino-15N2] fapyadenine, and 5-[2-13C,1,3-15N2] hydroxycytosine. Other 
chemicals are purchased from Sigma (St Louis, MO, USA) if not specified. 
2.2 Animal Surgical Procedures 
The present studies were conducted in adult male Fisher 344 rats or Sprague-
Dawley rats. All injury procedures were performed under isofluorane anesthesia and were 
approved by the Animal Care and Use Committee of the University of Kentucky. Every 
effort was made to minimize both the possible suffering and number of animals used. All 
animals were housed 2/cage on a 12 hour light/dark cycle with free access to water and 
food. 51 Young (3 mo), 30 Middle-aged (12 mo) and 27 Aged (22 mo) Fisher-344 rats 
(205-500 g/animal) were subjected to a unilateral cortical impact on the surface of the 
brain utilizing an electronic controlled pneumatic impact device (ECPI) previously 
described (Baldwin and Scheff, 1996) and performed by Dr. Stephen Scheffs laboratory. 
Briefly, each animal was anesthetized with 2% isofluorane and placed in a Kopf 
stereotaxic frame with the incisor bar set at -5. Following a midline incision and 
retraction of the skin, a 6 mm diameter craniotomy was made approximately midway 
between bregma and lambda with a Michele hand trephine (Miltex, NY). The skull disk 
was removed without disturbing the dura. The exposed brain was injured using the ECPI. 
The impactor rod had a beveled tip with a 5 mm diameter that was used to compress the 
cortex to a depth of 1.3 mm at 3.5m/sec. Following injury, Surgicel (Johnson & Johnson, 
TX) was placed over the injury site, the skull disk replaced, and sealed with a thin layer 
of dental acrylic. The incision was closed with surgical staples and animals maintained at 
35 °C--37 °C with a heating pad. Eighteen young (3 month), 6 middle aged (12 month), 
and 6 aged Fisher-344 rats were subjected to sham surgery following the same procedure 
except brains were not impacted. For the creatine study, Sprague-Dawley rats were used. 
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The animals were fed a 1% (N = 8) or 2% (N = 8) creatine diet 2 weeks before surgery. 
Control animals (N = 8) were fed a regular diet. Animals on the creatine or regular diet 
were subjected to ECPI following the procedure described above. 
2.3 Tissue Collection 
Animals were anesthetized using 2% isofluorane and subjected to decapitation 
and the brains removed. For studies of HNE and acrolein in TBI in aging, twenty-one 
young, twenty-four middle aged, and twenty-one aged Fisher-344 rats were used.  Ten 
young, ten middle-aged, and eight aged animals were allowed to survive for 24 h. Eleven 
young, fourteen middle-aged, and thirteen aged animals were euthanized 7 days post 
injury. To study the effects of TBI and aging on DNA oxidation, young (N = 6), middle-
aged (N = 6), and aged (N = 6) Fisher-344 rats were subjected to injury, an additional 6 
middle-aged, 6 aged animals were subjected to sham surgery. Injured and sham animals 
were euthanized 24 h post injury. For mitochondrial proteomics studies, 12 injured young 
Fisher-344 rats were sacrificed 1 hr post injury, 12 injured and 12 sham young animals 
sacrificed 24 hr post injury. All animals used in these studies were dissected on ice 
following decapitation. Ipsilateral (IP) and contralateral (CON) cortex and hippocampus 
were obtained and then frozen immediately in liquid nitrogen. In addition, four naive rats 
were anesthetized using isofluorane and brains were extracted as described for injured 
animals. An additional four naive animals were anesthetized using isofluorane and brains 
flash-frozen in skull using liquid nitrogen following a midline incision. The animals were 
stored at -80°C, and cortex and hippocampus were extracted the next day. 
For creatine studies, 24 young (3 month) Sprague-Dawley rats were provided a 
creatine supplementation or regular diet for 2 weeks and were sacrificed at one day after 
injury. IP cortex and hippocampus and CON cortex and hippocampus were dissected as 
described above. All the tissue samples were stored at -80°C until used for analysis. 
2.4 Method for Estimating Tissue Sparing 
In order to examine tissue sparing/loss in TBI in aging, 6 young, 6 middle-aged 
and 5 aged animals were subjected to injury, overdosed with sodium pentobarbital and 
transcardially perfused with 0.1 M phosphate-buffered saline (PBS, pH 7.4) followed by 
4% paraformaldehyde in PBS, and decapitated. Whole brains were removed, postfixed in 
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4% paraformaldehyde containing 10% sucrose at 4°C overnight and subsequently 
cryoprotected in a 20% sucrose/4% paraformaldehyde solution for 24 hrs. Coronal 50 μm 
sections were cut with a cryostat throughout the rostral-caudal extent of the injured cortex 
extending from the septal area to the posterior aspect of the hippocampus. Sections were 
stained with cresyl violet and subjected to image analysis (NIH Image v. 1.62). 
Quantitative assessment of spared tissue employed the Cavalieri method as previously 
described (Michel and Cruz-Orive, 1988; Sullivan et al., 1999). The amount of tissue 
sparing was expressed as percentage of the total cortical volume of injured hemisphere 
compared to the contralateral uninjured hemisphere. In this way each animal is used as its 
own control. These methods obviate a need to adjust values due to possible differential 
shrinkage resulting from fixation and tissue processing. A total of twelve evenly spaced 
sections were used for each animal. All sections were assessed blind with respect to age 
group. 
2.5 Tissue Processing for Enzyme Activity and Oxidative Stress Assays 
Tissue samples (cortex, peumbra, and hippocampus) for enzyme and lipid 
peroxidation assays were homogenized using a chilled Teflon Dounce homogenizer on 
ice in 1 mL HEPES buffer (pH 7.4), containing 137 mM NaCl, 4.6 mM KCl, 1.1 mM 
KH2PO4, 0.6 mM MgSO4, pepstatin A (1 µM), leupeptin (1.2 µM), aprotinin (0.1 µM) 
and PMSF (0.23 mM). Samples were centrifuged at 100,000 × g for one hour at 4 °C for 
1 hour and the supernatant were kept for analyses. 
2.6 Protein Assay 
Total protein concentrations were determined using the Pierce BCA method 
(Sigma, St. Louis, MO). In detail, a UV-Vis spectrometer (Labsystem Multiscan 
MCC/340) was programmed using protein standards with concentrations of 0, 1, 5, 10, 
15, and 20 μg/μl. For the protein assay, standards were loaded in duplicate sequentially in 
the “A” row of 96-well plate, and protein samples were loaded in duplicate in other wells 
of the same plate.  After adding 100 μL BCA reagent (bicinchoninic acid, containing 1% 
Cu2+), the volume in each well was 200 μL, and the plate was incubated at 37 °C for 20 
min. The Cu2+ was reduced to Cu+, which coordinates with bicinchoninate to form a 
complex with purple color that absorbs at 562 nm. The plate was read at wavelength of 
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562 nm using a multiwell plate reader and the data were converted to protein 
concentration in the well based on calibration curve from known protein standards. 
2.7 Method of Nuclear DNA Isolation 
The method of Mecocci et al. (Mecocci et al., 1993) with modification (Wang et 
al., 2005) was used to isolate nuclear DNA. Briefly, brain samples were homogenized on 
ice using a Teflon-coated Dounce homogenizer in MSB-Ca2+ buffer (pH 7.5), containing 
0.21 M mannitol, 0.07 M sucrose, 0.05 M Tris-HCl, 3 mM CaCl2. Na2EDTA was added 
to the homogenate with a final concentration of 0.01 M. The homogenate was centrifuged 
at 600 × g and 4 °C for 5 min, and nuclear pellets collected, rinsed in MSB-Ca2+ and 
repelleted. The pellets were suspended in 700 µl digestion buffer ( 0.5% sodium dodecyl 
sulfate, 0.05 M Tris-HCl, 0.1 M Na2EDTA) with proteinase K (0.5 mg/ml) in a 55 °C 
water-bath overnight. After digestion, 30 µl 5 M NaCl solution was added, and solution 
extracted 3 times with phenol (containing 5.5 mM 8-hydroxyquinoline) and chloroform 
(containing 4% isoamyl) to remove proteins from the digestion mixture. 8-
Hydroxyquinoline was used to avoid artificial oxidation as previously described (Wang et 
al., 2005). Following extraction, the upper aqueous layer was collected and 20 µl NaCl (5 
M) and two volumes of cold absolute ethanol added, and the DNA precipitated. 
Following centrifugation, the DNA was collected, washed three times using 60% ethanol, 
and dried.  The isolated DNA was dissolved in autoclaved water, and purity and 
concentration measured at 260 nm and 280 nm using a Genesys 10 UV/Vis spectrometer 
(Rochester, NY, USA).  
2.8 Isolation of Mitochondria 
A modification of the procedure by Mecocci et al (1993) was used to isolate 
mitochondria (Mecocci et al., 1993). The cortices or hippocampi from three animals were 
used to make a pooled sample. Brain samples were homogenized on ice using a Teflon-
coated Dounce homogenizer in MSB-Ca2+ buffer. The homogenate was centrifuged at 
600 × g for 5 min at 4 °C (Beckman Avanti J25 centrifuge), and the supernatant 
collected. The supernatant was then centrifuged at 20,000 × g for 20 min, and a 
mitochondrial enriched fraction obtained. The raw mitochondria were suspended
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Figure 2.1. Scheme of nuclear DNA isolation and representative molecular structure of 
derivatized DNA bases. 
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in 2 mL MSB-Ca2+ buffer, loaded on the top of Percoll/ MSB-Ca2+ gradient (1:1) in a 10 
mL centrifuge tube, and centrifuged at 50,000 × g for 1 h (Beckman optima L-90K 
ultracentrifuge). Several bands were observed after centrifugation and the light brown 
band (ρ = 1.035) was collected. This fraction was centrifuged at 10,000 × g at 4 °C to 
obtain enriched mitochondria. The mitochondrial pellets were washed twice using MSB-
Ca2+ buffer. The pellets were homogenized in micro Douncer homogenizers on ice using 
distilled water, and the protein concentration measured using the Pierce BCA method. 
Four samples (75 μg) for each group were pooled, and aliquoted to 100 μg samples for 
proteomics. 
2.9 4-Hydroxynonenal and Acrolein Assay 
Dot-blot analyses of HNE and acrolein modified proteins were carried out using a 
Schleicher & Schuell Dot-blot apparatus, and the method described by Saiki et al. with 
modification (Saiki et al., 1986). Briefly, 20 μg of 100,000 × g supernatant protein were 
loaded in triplicate onto nitrocellulose membrane in a 40-50 μL volume.  Vacuum was 
applied until the solution was evacuated from the wells. After air drying, blots were 
incubated overnight in 5% dry milk in 0.05% Tween-20/tris buffered saline (TTBS, 0.1 
M Tris-HCl, 0.155M NaCl, pH = 7.5) to block nonspecific binding of the primary 
antibody. Blots were probed with a 1:2000 dilution of anti-HNE (Alpha Diagnostic, San 
Antonio, TX) or anti-acrolein (United States Biological, Swampscott, MA) polyclonal 
antibodies for 1 h at room temperature, washed in TTBS 3 × 10 minutes and then 
incubated with a 1:3000 dilution of horseradish peroxidase-conjugated goat anti-rabbit 
antibody for 1 h.  Detection of bound antibodies was achieved by enhanced 
chemiluminescence (Amersham ECLTM western blotting detection reagents, Amersham 
Pharmacia Biotech, Piscataway, NJ) and exposure of membrane to Hyperfilm (Film 
developer, Kodak, 2000). Blots were scanned and measured using Scion Image (NIH). 
The average density of the triplicate dots was calculated for HNE or acrolein content in 
an individual sample. 
To validate linearity of response of the dot-blots, aliquots of 100,000 × g protein 
from a representative rat were incubated for 4 h at 37 °C with increasing concentration of 
HNE (10, 25, 50 100 μM) or acrolein (1.0, 5.0, 10, 25 μM). The acrolein and HNE spiked 
sample were subjected to dot-blot analyses as described above. 
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2.10 Enzyme Acyivity Assays 
 The enzyme activity could reflect the antioxidant capacity of cell, and shows the 
antioxidant response of cells following injury. In this dissertation, MnSOD, Cu/ZnSOD, 
GPx, GSSG-R, and GST activities were quantified using UV/Vis spectrometry.   
2.10.1 Superoxide Dismutase  
The method for assay of total SOD (Cu/Zn- and MnSOD) activity was that of 
Misra and Fridovich (Misra and Fridovich, 1972) as modified by Mizuno (Mizuno, 
1984). Briefly, 70-µl aliquots of the 100,000 × g supernatant were placed in UV-grade 
cuvettes and 1.46 mL 68mM NaH2PO4 containing 1.35 mM EDTA (pH 7.8), 100 µL 4 
mM xanthine, 170 µL 3.53 mM epinephrine (pH 11.5) added. Following incubation at 30 
ºC for 5 minutes, 10 µL xanthine oxidase was added to the solution and the absorbance 
followed at 320 nm (Genesys 10 UV, Rochester, NY, USA) for 3 minutes. The blank for 
the assay contained 70 µL supernatant boiled in water for 5 minutes. For MnSOD, the 
same protocol was followed with the addition of 200 µL 20 mM KCN. Enzyme activities 
were expressed as units per microgram protein, where 1 unit reduces the absorbance 
change by 50%. Cu/Zn activity was obtained by subtracting MnSOD activity from total 
activity. Activities are expressed as mean ± SD percent of control. 
2.10.2 Glutathione Transferase  
GST activity was assayed using the method of Ricci et al, which measures the rate 
of conjugation of 7-chloro-4-nitrobenzo-2-oxa-1, 3-diazole (NBD-Cl) with glutathione 
catalyzed by glutathione transferase (Ricci et al., 1994). The NBD-Cl complex is a stable, 
yellow compound that strongly absorbs at 419 nm with a molar absorption coefficient of 
14.5 mM-1cm-1. For the assay, 1.6 mL of 0.1 M sodium acetate buffer (pH 5.0) was mixed 
with 200 µL  0.2 mM NBD-Cl  and 100 µl 0.5 mM reduced glutathione. The reaction was 
initiated by addition of 100 µL aliquots of the 100,000 × g tissue supernatant. The 
absorbance was followed for 3 minutes. Enzyme activity was expressed in units/μg total 
protein, with 1 unit = 1 nmol   NBD-Cl complex formed per minute. Results are 
expressed as mean ± SD percentage of control activity. 
2.10.3 Glutathione Peroxidase  
For GPx activity, the method of Paglia and Valentine (Paglia and Valentine, 
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1967) as modified by Mizuno (Mizuno, 1984) was followed, which measures the rate of 
oxidation of reduced glutathione to oxidized glutathione by H2O2 as catalyzed by GSH-
Px present in the tissue supernatant. For  the assay, 100 µL aliquots of the 100,000 × g 
supernatant were added to 1.68 mL 68 mM KH2PO4 buffer (pH 7.0) containing 1mM 
EDTA, 100 µL 2 mM  NADPH, 10 µL 66 U/mL GSSG reductase, 10 µL 200 mM 
sodium azide. The assay was initiated with 100 µL 15 mM H2O2.  The decrease in 
absorbance was followed for 2 minutes at 340 nm. Quantification was based on a molar 
absorption coefficient of 6,270 M-1 cm-1 for NADPH (Braughler et al., 1986). The blank 
in the enzyme assay consisted of 100 µL supernatant heated at 100 ºC for 5 minutes, and 
its value was subtracted from the sample value to correct for nonenzymatic oxidation of 
glutathione. Activity of the enzyme was expressed in units/μg total protein, with 1 unit = 
1 nmol NADPH oxidized per minute, and final data for the activity in ipsilateral tissue 
was expressed as mean ± SD percent of control activity. 
2.10.4 Glutathione Reductase Assay 
The method of assay for GSSG-R is from Mizuno (Mizuno, 1984) and is based on 
the reduction of oxidized glutathione by GSSG-R and exogenous NADPH. The assay 
measures a loss in absorbance at 340 nm as NADPH is converted to NADP+. One-
hundred-microliter aliquots of the 100,000 × g supernatant were added to 1.58 mL 68 
mM KH2PO4 buffer containing 1 mM EDTA with 100 μL 2 mM NADPH. The 
absorbance was followed at 340 nm for 3 minutes following initiation of the reaction 
initiation by addition of 220 μL 13.6 mM oxidized glutathione. Enzyme activities were 
calculated as described for GPx and expressed as mean ± SD percent of control activity. 
2.11 DNA Hydrolysis and Derivatization 
For GC/MS-SIM, 20 µg DNA was aliquoted into glass vials to which internal 
standards (1 μg for each) were added, and the samples freeze-dried overnight under 
vacuum. Acid hydrolysis was performed by heating the DNA and standards in 250 µl 
90% formic acid in evacuated and sealed conical glass tubes for 30 min at 140 °C. After 
lyophilization, 200 µl derivatization reagent (pyridine:BSTFA 1:1 (vol/vol)) added, the 
tube evacuated, and derivatization carried out at room temperature for 2 h. The 
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derivatized samples (Figure 2.1) were freeze-dried, and 20 µl BSTFA added immediately 
before GC/MS injection. 
2.12 GC/MS-SIM 
Derivatized DNA samples/standards were analyzed on a Hewlett-Packard 5972A 
mass selective detector interfaced with a Hewlett-Packard 6890 gas chromatograph and 
equipped with a computer workstation. The injection port and the GC/MS interface were 
kept at 250 °C. Separation was performed on a fused-silica capillary column (30 m × 
0.25mm i.d.) coated with cross-linked 5% phenylmethylsiloxane (film thickness 0.25 µm, 
HP-5MS). Ultra pure helium was used as carrier gas with a constant flow rate of 1.1 
ml/min.  Derivatized samples (2 µl) were injected directly into the GC injection port 
using the splitless mode. The initial temperature was held for 2 min after sample 
injection, and the oven temperature was programmed through the following four ramps: 
ramp 1, column temperature was increased from 100 °C to 178 °C at a rate of 3 °C /min; 
ramp 2, temperature was increased from 178 °C to 181 °C at rate 0.3 °C /min; ramp 3, 
column temperature was raised at a rate of 3 °C /min from 181 °C to 208 °C; ramp 4, rate 
was 10 °C /min from 208 °C to 280 °C. The final temperature was maintained for 2 min. 
The total run time was 56.2 min for each sample and the temperature of the mass 
spectrometer ion source was maintained at 180 °C. Mass spectra were recorded from 9 to 
56.2 min. The five bases of interest were well separated at following retention times: 5-
hydroxycytosine  
(22.0 min), fapyadenine (28.0 min), 8-hydroxyadenine (32.5 min), fapyguanine (39.8 
min) and 8-hydroxyguanine (46.0 min) (Figure 2.2). 
2.13 Isotope-coded Affinity Tag (ICAT) Labeling Mitochondrial Protein for MS 
Analysis 
In the current study,  100 μg mitochondrial proteins from sham animals and 
injured animals were labeled with light (C10H17N3O3) and heavy (13C9CH17N3O3)  ICAT 
reagents (ICAT kit, Applied Biosystems, Foster City, CA), respectively as following 
manufacturer’s instructions (Figure 2.3).  Briefly, mitochondrial protein from sham 
animals and the same amount of protein from injured animals were aliquoted, denatured 
by adding 80 µL denaturing buffer and 2 µL reducing reagent, and heated in a boiling 
water bath for 10 min. For labeling, proteins from injured animals were mixed with 
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Figure 2.2.Representative chromatogram of DNA oxidized adducts.  
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Figure 2.3. Scheme of ICAT labeling. 
Control Injured 
combine 
Mixture of Labeled Proteins  
 
Light ICAT Heavy ICAT 
Peptides labeled by ICAT 
Cation exchange 
Avidin exchange 
Pure peptides labeled by ICAT 
Cleaving reagent 
Analyze by 2D-LC/MS/MS 
Protein identification and quantification.  
Affinity Tag (Biotin)
Cleavable Linker
Isotope-Coded Tag
13C9CH17N3O3/C10H17N3O3
NH
I
ICAT
Trypsinization 
Tag attached to 
peptide in  
2D-LC/MS/MS 
analysis 
 45
heavy ICAT reagent, and proteins from control mixed with light ICAT reagent. The 
labeling was performed in water bath at 37 °C for 2 hours. During labeling, proteins 
containing cysteine residues react with iodoacetamine group of the ICAT reagent. 
Proteins from control and injured animals were then combined and digested 16 h at 37 °C 
by using sequencing grade modified trypsin (Promega, Madison, WI). Excess ICAT 
reagents, Tris(2-carboxyethyl)phosphine (TCEP) and SDS in sample mixtures were 
removed using cation exchange. Resulting peptides were added to avidin column that 
isolated ICAT labeled peptides. The isolated labeled peptides were lyophilized, 
resuspended in trifluoroacetic acid (TFA) and incubated in a water bath 2 hours at 37 °C 
to cleave the biotin portion of the ICAT tags. Peptides were dried in a speed vacuum 
centrifuge and reconstituted in 10 µL 5% ACN/95% aqueous formatic acid (0.1%) and 
extracted again using C18 zip-tips prior to 2-D-LC/MS/MS. 
2.14 Analysis of ICAT-labeled Peptide Samples Using 2D-HPLC and Mass 
Spectrometry 
 In this study, ICAT lebeled samples were analyzed using 2D-LC/MS/MS 
(ThermoFinnigan Deca quadruple ion trap mass spectrometer), and peptides were 
separated using 2-D LC (Peng and Gygi, 2001; Wolters et al., 2001). 2D LC-MS/MS was 
carried out using a column composed of strong cation exchange (SCX) and reverse phase 
C18 resins and performed by Dr. Lynn in his lab. The peptides were separated based on 
charge using SCX, and further separated on C18 residue based on hydrophobicity. An 
ammonium acetate gradient from 0 to 250 mM was used for peptide separation in SCX. 
Thirteen individual chromatographic profiles were obtained for each sample, indicating 
13 fractions separated by SCX. Each fraction from SCX separation was subjected to 
further separation using an acetonitrile gradient from 5% ACN/95% aqueous formic acid 
(0.1%) to 70% ACN/aqueous 30% formic acid (0.1%) over 80 min (Figure 2.4). Peptides 
in the column effluent were directly subjected to electrospray ionization, and introduced 
into a Finnigan LCQ Deca ion trap mass spectrometer for mass analysis. Mass spectra of 
peptides were saved for later data base searches. 
2.15 Protein Identification 
In order to identify proteins, acquired tandem mass spectra of peptides were 
subjected to protein database searches using TurboSEQUEST (ThermoFinnigan). First  
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of all, modifications were made to the protein database and the search parameters of 
TurboSEQUEST. Briefly, a sub-database of the Uniprot SwissProt non-redundant 
rat/mouse protein database was set up using the Fasta Database Utilities of Bioworks. 
This sub-database was specified to have only tryptic, cysteine-containing peptides. In 
addition, search parameters of TurboSEQUEST were edited to expect static 
modifications of cysteine residues that corresponded to 227.1273 u which is the mass of 
the light ICAT label or 236.16 u, the mass of expected heavy ICAT modifications. 
TurboSEQUEST results were filtered by cross-correlation score (Xcorr) criteria, Xcorr > 
1.8 for +1 peptides, >2.3 for +2 peptides, and >3.0 for +3 peptides. Proteins identified in 
database search were scored and the protein with best score was considered the hit in the 
data base search. Relative ratios of heavy/light (injured/sham) peptides were obtained 
using the XPRESS program of Bioworks 3.1 (Figure 2.5). ICAT ratios for all tryptic 
peptides identified from a protein were averaged to obtain the relative ratio of that 
protein. 
2.16 Western Blot 
 To verify the purity of mitochondria isolated using our extraction protocol, 
mitochondrial proteins, cytosolic protein samples and nuclear specimens were subjected 
to SDS-PAGE on a 4-20% gradient gel (Bio-Rad) and transferred to nitrocellulose 
membrane for Western blot analysis.  The blots were incubated 1 h in 5% dry milk in 
0.05% Tween-20/Tris buffered saline (TTBS) to block nonspecific binding of the primary 
antibodies. Blots were incubated with a 1:3000 dilution of anti-VDAC (Calbiochem, 
1:3000), anti-Lamin B (1:1000) or anti-MAP-2 (1: 1000) primary antibody for 1 h at 
room temperature, washed in TTBS 3 × 10 min and then incubated with a 1:3000 dilution 
of horseradish peroxidase-conjugated goat anti-rabbit for 1 h.  Detection of bound 
antibodies was achieved by enhanced chemiluminescence (Amerisham Pharmacia 
Biotech) and exposure of the membrane to Hyperfilm (Amerisham) (Figure 2.6). 
To verify proteomics data, equal amounts of mitochondrial protein (20 µg) from 3 
independent samples from IP or CON cortex at each time point were subjected to 
Western blot and probed using anti-VDAC (Calbiochem, 1:3000) or anti-hexokinase 1 
(Chemicon, 1:3000) antibodies. Staining intensity was quantified using Scion Image  
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Figure 2.5. Representative chromatogram showing the heavy and light ICAT labeled 
peptide
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Figure 2.6. Representative Western blots of mitochondrial, cytosolic, and nuclear protein 
specimens to evaluate purity of fractions. VDAC is a mitochondrial protein marker, 
Lamin B is a nuclear envelope protein, and MAP-2 is cytosolic protein. Results of the 
analyses show no cross contamination of fractions. 
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(NIH). The average band densities from three samples of IP or CON cortex at a time 
point indicates the protein content in the tissue at that time point.  
2.17 Statistical Analyses 
 A two-tailed Student t test was used for time course differences in lipid 
peroxidation and enzyme activities. A two-tailed Student Paired t test was used for IP and 
CON differences in lipid peroxidation, DNA oxidation, and antioxidant enzyme 
activities. Age dependent differences in enzyme activities, lipid peroxidation, DNA 
oxidation, and percent tissue sparing of the injured cortex were compared using one-way 
ANOVA and the student-Newman-Keuls post hoc test for age dependent differences 
using the commercially available ABSTAT software. Significance was established as p < 
0.05. One-way ANOVA and student-Newman-Keuls post hoc test was also used for 
enzyme and lipid peroxidation measures in the creatine study. For ICAT proteomics data, 
one-sample t tests were used to calculate the p values for the rejection of the null 
hypothesis that the mean ratio of the peak areas is 1.0 (signifying no difference in the 
protein levels between injured animals and sham). Correction for multiple comparisons 
was done according to the Bonferroni procedure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Changxing Shao 2007 
 51
Chapter Three 
Experimental Results 
 
3.1. Oxidative Damage and Antioxidant Enzyme Activities in TBI in Aging 
 Oxidative damage is shown to play a key role in neurodegeneration following 
TBI. In order to quantify oxidative damage in aging, markers of oxidative damage, 4-
HNE, acrolein, 8-OHG, FG, 8-OHA, FA, and 5-OHC, were quantified in cortex and 
hippocampus following TBI. To evaluate antioxidant defense capacity, MnSOD, 
Cu/ZnSOD, GPx, GSSG-R, and GST activities were measured. 
3.1.1 Assessment of Tissue Sparing in TBI in Aging 
At 7 days post injury, 6 young, 6 middle-aged and 5 aged rats were assessed for 
cortical tissue sparing immediately below the site of impact (Figure 3.1). Analysis of 
variance showed a statistically significant difference among group means [F(2,14) = 
17.36, p< 0.001]. Post-hoc analysis showed significant differences (p < 0.05) between 
young and middle aged, and young and aged groups. Young animals showed 89.4 ± 4.4% 
(SD) tissue sparing with middle aged and aged animals showing 77.1 ± 3.9% (SD) and 
77.0 ± 3.8% (SD), respectively (p <0.05) (Figure 3.2). There were no significant 
differences in tissue sparing between middle aged and aged animals. 
3.1.2 HNE and Acrolein Dot Blot Calibration 
To validate antibody response for the dot blot assays, representative protein 
samples were incubated with HNE or acrolein and subjected to dot blot analysis. Figure 
3.3 shows a statistically significant linear response with increasing HNE levels (r = 0.95, 
p < 0.0001 ). Figure 4.4 shows similar results for acrolein (r = 0.84, p = 0.0006 ). 
3.1.3 Comparison of HNE and Acrolein in Sham, and Naive Animals with and 
without Flash-freezing Prior to Cervical Dislocation and Tissue Extraction 
In order to determine if artifactual ROS are produced during post mortem tissue 
extraction, HNE and acrolein levels of naive animals with and without insito flash-
freezing before tissue extraction were evaluated. Our results show no significant 
differences in HNE or acrolein levels between the animals subjected to different tissue 
extraction methods (Figure. 3.5). Comparison of HNE and acrolein levels in CON cortex 
and hippocampus of injured animals to levels in CON and IP tissues of sham,
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Figure 3.1. Representative rat brain and coronal section at 7 days post injury. 
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Figure 3.2. Percentage of tissue sparing in Fisher-344 rats subjected to 1.5 mm injury. 
ANOVA showed a significant difference between the three age groups. Bars represent 
the mean ± SD. Student-Newman-Keuls, *p < 0.05. 
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Figure 3.3. Correlation of HNE immunohistochemistry staining of protein samples 
incubated with increasing concentrations of HNE. Each sample was loaded in triplicate. 
Calibration curve of HNE concentration vs immunohistochemical staining, r = 0.9532 
(bottom). Representative dot-blot with increasing HNE concentrations (top). 
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Figure 3.4. Correlation of acrolein immunohistochemical staining of protein samples 
incubated with increasing concentrations of acrolein. Each sample was loaded in 
triplicate. Calibration curve of acrolein concentration vs immunohistochemical staining, r 
= 0.8414 (bottom). Representative dot-blot with increasing acrolein concentrations (top). 
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Figure. 3.5. 4-Hydroxynonenal and acrolein levels in cortex and hippocampus of naïve 
animals with and without flash-freezing before brain extraction. For flash-frozen animals, 
the brains were frozen using liquid nitrogen following isofluorane anesthetization and 
midline cranial incision. The frozen animals were stored at -80 °C, and the brain removed 
the next day. Bars represent mean ± SD of animals without flash-freezing before cervical 
dislocation. 
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animals showed no significant differences (Figure. 3.6). 
3.1.4 HNE and Acrolein Relative Content in Hippocampus Following TBI in Aging 
To evaluate lipid peroxidation in IP and CON hippocampus 1 and 7 days post 
injury, we measured levels of HNE and acrolein. Because the CCI injury model produces 
a gradient of secondary injury with no significant changes of antioxidant response in 
distal areas (DeKosky et al., 2004), we used CON tissue as internal controls to limit 
animal variability, and focused on oxidative response in IP tissues. The data in IP tissues 
are expressed as percentage of CON tissues and show  HNE levels in IP hippocampus are 
significantly (p < 0.01) increased 24 h post injury in young (230.1 ± 53.4%), middle aged 
(253.2 ± 45.1%) and aged animals (288.6 ± 46.3%) (Figure 3.7). Statistical analyses 
showed an age dependent difference [F(2,27) = 3.2334, p < 0.05], with aged animals 
showing significantly higher HNE levels than young animals (p < 0.05) 24 h post injury. 
Another lipid peroxidation marker, acrolein, showed a significant increase (p < 0.05) in 
aged IP hippocampus compared with CON hippocampus. ANOVA showed a significant 
age dependent increase 24 h post injury [F(2,27) = 3.5055, p < 0.05], although the 
differences were more modest compared with HNE levels in aging (Figure. 3.7). At 7 
days post injury, HNE levels remained elevated in an age dependent manner [F(2,19) = 
9.598, p < 0.01]. HNE levels in IP hippocampus of aged animals were significantly 
increased compared with aged CON hippocampus (Figure 3.8). For young (104.3 ± 
10.3%) and middle aged (138.8 ± 55.6%) animals, the changes in HNE levels in IP 
hippocampus were not statistically significant compared to CON tissues. No significant 
changes were observed for acrolein in hippocampus 7 days post injury for any age group 
(Figure 3.8). 
3.1.5 HNE and Acrolein Relative Content in Cortex Following TBI in Aging 
 In cortex, mechanical injury triggers cell necrosis and apoptosis with concomitant 
production of ROS and toxic byproducts of lipid peroxidation including HNE and 
acrolein. In the current study, HNE and acrolein levels in IP and CON cortices were 
measured, and expressed as percentage of CON cortex. Statistical 
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Figure. 3.6. 4-Hydroxynonenal and acrolein levels in CON tissues of injured animals and 
CON and IP tissues of sham animals. Bars represent mean ± SD of CON tissues of 
injured animals. 
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Figure 3.7. HNE and acrolein levels in hippocampus at 24 h post injury. Bars represent 
the mean ± SD. *p < 0.01 compared with CON hippocampus of the corresponding age, $p 
< 0.05 compared with young animals IP hippocampus. 
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Figure 3.8. HNE and acrolein levels in hippocampus at 7 day post injury. Bars represent 
the mean ± SD. *p < 0.01 compared with CON hippocampus of the corresponding age, $p 
< 0.05 compared with young animals IP hippocampus. 
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analysis of levels of HNE modified proteins in IP cortex in young, middle aged, and aged 
animals 24 h post injury showed HNE levels in IP cortices were significantly (p < 0.01) 
increased compared to CON tissues for each age. No age dependent changes were 
observed among young, middle-aged, and aged animals (Table 3.1). Acrolein levels in IP 
cortex did not change significantly in any age group compared with their CON cortices at 
24 h post injury. At 7 days post injury, HNE levels increased significantly (p < 0.01) for 
middle aged animals and showed a trend toward an elevation (p < 0.1) for aged animals 
in cortex (Table 3.1). Post hoc testing following ANOVA showed HNE levels were 
significantly higher in middle aged animals compared with young animals [F(2,17) = 
87.037, p < 0.001]. Our data also showed significantly increased acrolein in middle aged 
and aged animals compared with young animals 7 days post injury (Table 3.1). 
3.1.6 DNA Oxidative Damage in TBI in Aging 
Using the method of Mecocci et al. (1993) as modified in our laboratory (Wang et al., 
2005), we isolated nuclei with high purity. Using stable isotope labeled internal 
standards, multiple oxidized DNA base adducts were quantified, providing a 
comprehensive measure of DNA oxidation. Our data show an age dependent increase of 
8-hydroxyguanine levels in IP cortex [F(11,66) = 6.76, p < 0.0001] and hippocampus 
[F(11,67) = 5.93, p < 0.0001] of injured animals (Figure 3.9 and 3.10).  8-OHG levels in 
IP cortex of aged injured animals were significantly (p < 0.05) increased compared to 
young and middle aged animals. In addition, levels of 8-OHG in aged and middle aged IP 
hippocampus were significantly (p < 0.05) higher than young animals. Our data also 
show 8-hydroxyguanine levels in aged IP cortex of injured animals were significantly (p 
< 0.05) increased compared to CON and IP cortices of aged animals subjected to sham 
surgery (Figure 3.9). In hippocampus, we observed significantly (p < 0.05) higher levels 
of 8-hydroxyguanine in middle aged and aged IP hippocampus compared to age matched 
CON hippocampus. 8-hydroxyguanine levels in IP hippocampus of sham middle aged 
and aged animals were also significantly increased compared to IP hippocampus of 
young animals (Figure 3.10). FP, 8-OHA, FA and 5-OHC levels (Tables 3.2 and 3.3) 
were not significantly different in IP hippocampus or cortex among the three age groups, 
or between injured and sham animals.  
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Table 3.1.  HNE and acrolein levels and antioxidant enzyme activities in cortex in aging. 
 24 h post injury 7 days post injury 
 CON IP CON IP 
Young 100 ± 15.4 166.5 ± 17.8† 100 ± 8.0 110.7 ± 16.0 
Middle aged 100 ± 18.8 166.5 ± 29.9† 100 ± 7.8 371.7 ± 28.7*,† 
HNE 
Aged 100 ± 12.0 160.8 ± 22.7† 100 ± 5.8 148.2 ± 52.9$ 
Young 100 ± 13.0 103.1 ± 19.5 100 ± 3.5 104.7 ± 10.6 
Middle aged 100 ± 10.1 104.4 ± 19.3 100 ± 1.0 179.3 ± 38.9*† 
acrolein 
Aged 100 ± 6.9 115.2 ± 30.0 100 ± 0.5 169.2 ± 72.8*,# 
Young 100 ± 41.0 98.7 ± 28.2 100 ± 8.3 73.2 ± 12.3† 
Middle aged 100 ± 30.0 63.5 ± 27.2*,# 100 ± 21.2 61.1 ± 16.5† 
MnSOD 
Aged 100 ± 34.6 60.7 ± 20.8*,† 100 ± 26.5 48.4 ± 20.3† 
Young 100 ± 21.7 71.9 ± 21.1† 100 ± 8.4 77.7 ± 12.7† 
Middle aged 100 ± 22.8 97.7 ± 37.0 100 ± 9.8 63.8 ± 23.7† 
Cu/ZnSOD 
Aged 100 ± 16.2 92.4 ± 22.6 100 ± 30.7 54.1 ± 11.6† 
Young 100 ± 14.9 116.4 ± 35.3 100 ± 19.9 149.2 ± 38.8# 
Middle aged 100 ± 19.8 106.2 ± 30.3 100 ± 46.4 180.7 ± 106.3 
GPx 
Aged 100 ± 29.2 94.8 ± 40.2 100 ± 19.5 101.8 ± 31.0 
Young 100 ± 12.8 99.8 ± 20.0 100 ± 7.6 93.2 ± 22.5 
Middle aged 100 ± 11.0 81.5 ± 14.1*,† 100 ± 27.3 66.0 ± 33.8 
GSSG-R 
Aged 100 ± 20.9 82.0 ± 16.6*,# 100 ± 25.2 102.2 ± 29.4 
Young 100 ± 15.21 81.5 ± 17.7† 100 ± 4.9 65.3 ± 23.3† 
Middle aged 100 ± 11.6 69.6 ± 20.8† 100 ± 27.3 43.3 ± 18.6† 
GST 
Aged 100 ± 20.2 70.5 ± 20.7† 100 ± 25.2 87.7 ± 28.9$, # 
 
All values are mean ± SD. The value is percentage of that of CON tissue.* p < 0.05 
compared with activities in young IP tissues at the same time point. $ p < 0.05 compared 
with activities in middle aged IP tissues at the same time point. #p < 0.05, †p < 0.01 
compared with activities in CON hippocampus of the corresponding age. 
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Figure 3.9. 8-hydroxyguanine levels in cortex in TBI in aging. *p < 0.05 compared with 
young and middle aged IP cortex of injured animals; #p < 0.05 compared with CON 
cortex of injured aged animals; $p < 0.05 compared with aged CON cortex of injured 
animals. Results are expressed as mean ± SD. 
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Figure 3.10. 8-hydroxyguanine levels in hippocampus in TBI in aging. *p < 0.05 
compared with young IP hippo of injured animals, #p < 0.05 compared with young IP 
hippo of sham animals, $p < 0.05 compared with age matched CON hippo of injured 
animals. Results are expressed as mean ± SD. 
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Table 3.2. DNA oxidation levels in cortex. 
 
Results are expressed as mean ± SD. 
 FG 8-OHA FA 5-OHC 
sham 105.4 ± 60.0 7.4 ± 3.3 188.2 ± 111.7 17.2 ± 7.3 CON 
cortex injured 120.5 ± 63.2 6.7 ± 3.0 168.0 ± 65.5 13.5 ± 4.3 
sham 154.0 ± 61.2 13.0 ± 4.0 209.0 ± 81.9 23.9 ± 9.7 
Young 
animals IP 
cortex injured 160.7 ± 79.8 11.7 ± 4.6 279.0 ± 134.8 23.5 ± 10.4
sham 160.2 ± 39.9 9.5 ± 3.2 232.1 ± 103.4 16.5 ± 3.4 CON 
cortex injured 138.3 ± 75.6 11.5 ± 3.6 167.9 ± 84.6 18.7 ± 9.6 
sham 206.2 ± 82.4 15.0 ± 2.4 213.7 ± 102.6 23.1 ± 5.3 
Middle-
aged 
animals IP cortex injured 228.4 ± 91.4 15.4 ± 5.8 299.6 ± 90.2 29.8 ± 9.5 
sham 202.8 ± 34.9 11.4 ± 4.0 272.4 ± 78.3 14.9 ± 3.9 CON 
cortex injured 201.0 ± 86.3 11.2 ± 2.6 267.4 ± 91.2 19.3 ± 5.5 
sham 207.8 ± 83.6 16.6 ± 1.5 328.8 ± 141.4 28.9 ± 4.4 
Aged 
animals IP 
cortex injured 262.3 ± 114.7 16.6 ± 7.1 289.0 ± 89.3 27.8 ± 6.7 
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Table 3.3. DNA oxidation in hippocampus. 
 FG 8-OHA FA 5-OHC 
sham 135.0 ± 39.5 7.9 ± 5.0 207.7 ± 104.8 19.1 ± 9.8 CON 
hippo injured 133.5 ± 49.3 10.1 ± 4.6 314.7 ± 216.7 17.3 ± 9.1 
sham 143.2 ± 49.4 10.5 ± 7.6 326.4 ± 52.4 14.3 ± 5.3 
Young 
animals IP hippo injured 159.7 ± 25.0 12.5 ± 5.0 333.2 ± 114.5 20.3 ± 3.7 
sham 162.0 ± 64.0 11.1 ± 5.3 309.4 ± 66.1 22.5 ± 5.2 CON 
hippo injured 161.2 ± 29.2 10.2 ± 3.7 310.8 ± 128.4 21.0 ± 5.6 
sham 197.6 ± 51.3 10.2 ± 3.8 346.5 ± 133.1 24.1 ± 5.1 
Middle-
aged 
animals IP hippo injured 242.3 ± 50.8 10.1 ± 3.6 313.0 ± 78.6 24.2 ± 8.0 
sham 209.2 ± 60.5 10.1 ± 9.6 338.2 ± 152.3 19.6 ± 6.4 CON 
hippo injured 255.8 ± 50.4 10.6 ± 5.7 341.7 ± 75.0 24.9 ± 7.1 
sham 227.8 ± 64.2 13.3 ± 9.7 347.3± 78.7 23.4 ± 6.3 
Aged 
animals IP hippo injured 308.2 ± 92.6 8.8 ± 2.5 425.2 ± 151.6 30.3 ± 5.8 
 
Results are expressed as mean ± SD. 
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3.1.7 Antioxidant Enzyme Activities in IP Hippocampus and Cortex in Aging 
Measurement of markers of lipid peroxidation showed increased oxidative 
damage in aging following TBI. To determine if alterations in antioxidant enzyme 
capacity occurred as a function of age, Cu/Zn and MnSOD, GPx, GSSG-R and GST 
activities were determined in IP and CON hippocampus and cortex 24 h and 7 days post 
injury. The data from IP tissues were expressed as a percentage of CON tissues. At 24 h 
post injury, the hippocampus showed a trend toward decreased MnSOD activity (p < 0.1) 
for aged animals compared to aged CON hippocampus (Table 3.4). ANOVA showed a 
significant age dependent decrease of MnSOD [F(2,27) = 4.54, p < 0.05] in IP 
hippocampus,  with a more pronounced loss of  MnSOD activity (p < 0.05) in aged 
animals compared with middle aged animals. At 7 days post injury, our data showed 
MnSOD activities in aged animals decreased significantly (p < 0.01) compared with aged 
CON hippocampus, but not for young and middle-aged animals (Table 3.4). ANOVA 
[F(2,20) = 3.5004, p < 0.05] showed an age dependent decrease of MnSOD activity in IP 
hippocampus, with aged animals showing significantly lower activities compared with 
young animals. In IP cortex, our data showed MnSOD activity decreased significantly (p 
< 0.01) in middle aged and aged animals compared with their age matched CON cortices 
and also IP cortices of young animals 24 h post injury [F(2,25) = 5.9072, p < 0.01] (Table 
3.1). At 7 days post injury, young, middle aged and aged animals all showed significant 
(p < 0.01) depletion of MnSOD compared to their corresponding CON cortices, although 
there were no significant age dependent changes at this time point (Table 3.1). 
Analysis of Cu/ZnSOD activities showed no significant changes in IP hippocampus 
compared to CON tissues at 24 h post injury (Tables 3.1, 3.4). In cortex, Cu/ZnSOD 
activity deceased significantly in IP cortex compared with CON cortex for young animals 
at 24 h post injury. At 7 days post injury, Cu/ZnSOD activity decreased significantly in 
IP cortex compared to CON cortex for each age animals (Table 3.4). However, there 
were no age dependent changes observed for this enzyme activity at any time point. 
 Levels of GPx, which reduces oxidative stress by converting H2O2 and a 
variety of organic peroxides to stable alcohols and water, showed a trend of increase in 
young IP hippocampus 24 h post injury (Table 3.4). Only slight changes were observed in 
response to injury in middle aged and aged IP hippocampus (Table 3.4).
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Table 3.4. Antioxidant enzyme activities in hippocampus in aging. 
 24 h post injury 7 days post injury 
 CON IP CON IP 
Young 100 ± 21.1 97.7± 19.8 100 ± 19.1 95.8 ± 24.6 
Middle aged 100 ± 24.9 111.8 ± 23.5 100 ± 22.8 66.7 ± 38.9 
MnSOD 
Aged 100 ± 26.4 83.9 ± 17.9$ 100 ± 22.7 71.2 ± 8.9*† 
Young 100 ± 18.5 104.3 ± 22.5 100 ± 19.2 95.8 ± 10.1 
Middle aged 100 ± 21.7 115.8 ± 50.5 100 ± 33.4 129.5± 71.6 
Cu/ZnSOD 
Aged 100 ± 17.0 113.4 ± 24.7 100 ± 25.2 105.1 ± 12.1
Young 100 ± 31.6 169.3 ± 68.9 100 ± 32.0 143.9 ± 88.0
Middle aged 100 ± 41.0 111.0 ± 39.7* 100 ± 19.2 113.4 ± 13.1
GPx 
Aged 100 ± 26.4 99.6 ± 20.0* 100 ± 13.2 107.2 ± 14.0
Young 100 ± 9.3 111.2 ± 13.6 100 ± 9.4 98.1 ± 24.2 
Middle aged 100 ± 7.6 107.4 ± 8.8 100 ± 8.8 89.3 ± 6.1† 
GSSG-R 
Aged 100 ± 9.9 108.4 ± 18.0 100 ± 7.6 87.5 ± 8.7† 
Young 100 ± 7.3 95.9 ± 8.1 100 ± 12.0 94.3 ± 16.6 
Middle aged 100 ± 10.4 92.8 ± 12.6 100 ± 14.4 84.8 ± 14.6 
GST 
Aged 100 ± 17.7 94.1 ± 13.5 100 ± 8.1 87.7 ± 5.7† 
 
All values are mean ± SD. The value is percentage of that of CON tissue. * p < 0.05 
compared with activities in young IP tissues at the same time point. $ p < 0.05 compared 
with activities in middle aged IP tissues at the same time point. †p < 0.01 compared with 
activities in CON hippocampus of the corresponding age. 
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Statistical analysis showed GPx activity was significantly lower (p < 0.05) in middle aged 
and aged animals compared to young animals 24 h post injury in IP hippocampus.  In IP 
cortex, GPx activity did not change significantly in any age group 24 h post injury, 
although levels increased significantly (p < 0.05) in young animals 7 days post injury 
(Table 3.1). 
Glutathione transferase activities showed a significant decrease (p < 0.01) in IP 
cortices in young, middle aged and aged animals 24 h post injury compared with their 
CON cortices. At 7 days post injury, GST activities in young and middle aged IP cortices 
were also decreased significantly (p < 0.01) compared to CON cortices.   ANOVA 
showed GST activity was significantly lower in middle aged animals compared with aged 
animals at this time point (Table 3.1). In IP hippocampus, GST activities decreased 
significantly (p < 0.01) in aged animals compared with their corresponding CON 
hippocampi at 7 days post injury. However, no age dependent changes were observed at 
24 h or 7 days post injury (Table 3.4). 
 Another antioxidant enzyme, GSSG-R, which functions to reduce oxidized GSH 
to reduced GSH for participation in the GSH reaction, was significantly depleted in IP 
cortex (p < 0.01) of middle aged and aged animals compared to their CON cortices 24 h 
post injury. ANOVA showed GSSG-R activities were significantly (p < 0.05) lower in 
middle aged and aged animals compared with young animals at this time point (Table 
3.1). In IP hippocampus, GSSG-R activity did not change significantly compared to CON 
hippocampus for any age group 24 h post injury. At 7 days post injury, GSSG-R activity 
decreased significantly (p < 0.01) in middle aged and aged animals compared with their 
corresponding CON hippocampus. Our data showed no age dependent differences at 
either time point in IP hippocampus (Table 3.4).  
3.2 Protection of Creatine in TBI 
 Considerable research and effort has been directed toward finding efficient 
therapeutics that may reduce secondary injury, including oxidative damage. Although no 
breakthrough was emerged to date, some drug candidates have recently arisen. Creatine 
has been shown to be neuroprotective in other neurodegenerative diseases, although there 
has been limited study in TBI. In the current study, we evaluated creatine on oxidative 
damage in TBI.  
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3.2.1 HNE and Acrolein Relative Content in Hippocampus of Young Animals with 
Creatine Supplementation 
 The hippocampus is subject to mild mechanical injury in TBI, and experiences 
delayed secondary injury, including oxidative damage, which could trigger or accelerate 
neuron death in this tissue and result in memory deficits. Our previous study showed 
extensive oxidative stress in IP cortex and hippocampus 24 h post injury in animals 
following TBI. Creatine has been shown to ameliorate oxidative damage in TBI. To 
determine the effects of creatine on lipid peroxidation and antioxidant capacities, we 
measured oxidative damage using markers of lipid peroxidation at 24 h post injury in 
animals provided a creatine supplemented diet. Our data show HNE levels in IP 
hippocampus of animals treated with creatine decreases significantly (p < 0.05) compared 
to animals provided a control diet [F(2,23) = 4.3897, p < 0.05] (Figure. 3.11). Another 
lipid peroxidation marker, acrolein, showed the same trend in the three groups although it 
was not statistically significant (Figure. 3.11). No significant changes were observed for 
HNE or acrolein in IP hippocampi from animals treated with 1% and 2% creatine. For 
HNE and acrolein levels in CON hippocampus, there were no significant differences 
between creatine treated and control animals 
3.2.2 HNE and Acrolein Relative Content in Cortex of Young Animals provided 
Creatine Supplementation  
 In cortex, mechanical injury triggers cell necrosis and apoptosis, with 
production of ROS and toxic byproducts of lipid peroxidation, including HNE and 
acrolein. Analysis of levels of HNE modified proteins in IP cortex showed that HNE 
protein adducts  decreased significantly (p < 0.05) in IP cortex in animals provided 1% 
creatine supplemented diet compared to animals on a control diet [F(2,23) = 4.2013, p < 
0.05] (Figure. 3.12). Similarly, acrolein decreased as a trend in animals provided creatine 
diets. In CON cortex there were no significant changes in HNE or acrolein levels 
between control and creatine treated animals. 
 3.2.3 Antioxidant Enzyme Activities in Hippocampus and Cortex of Young Animals 
with Creatine Supplementation 
Measurement of markers of lipid peroxidation showed increased oxidative stress 
in TBI. Creatine has shown protective effects in a variety of neurodegenerative disease, 
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Figure 3.11. 4-Hydroxynonenal and acrolein levels in hippocampus following TBI. Bars 
represent mean ± SD of control. p* < 0.05 compared with control animals with regular 
diet. 
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Figure 3.12. 4-Hydroxynonenal and acrolein levels in hippocampus following TBI. Bars 
represent mean ± SD of control.  
*p < 0.05 compared with control animals with regular diet.
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including TBI. Our data showed reduced lipid peroxidation in animals on a creatine diet 
24 h post injury. To determine if protective effects of creatine supplementation in TBI are 
due to enhanced antioxidant capacities, activities of Cu/Zn and Mn SODs, GPx, GSSG-R 
and GST were determined in IP and CON hippocampus and cortex 24 h post injury. Our 
data show increased MnSOD activity [F(2,23) = 4.0551, p < 0.05] in IP hippocampus of 
animals with both 1% and 2% creatine diets compared to controls (Table 3.5). In CON 
hippocampus, MnSOD activity increased in 1% and 2% creatine treated animals, but did 
not reach statistical significance. In IP and CON cortex, our data showed creatine 
supplementation did not significantly improve MnSOD activity (Table 3.6). 
Our data showed Cu/ZnSOD activities increased significantly (p < 0.05) in IP 
hippocampus of 1% and 2% creatine treated animals relative to controls [F(2,23) = 
3.9727, p < 0.05] (Table 3.5). In IP cortex, Cu/ZnSOD activity also increased 
significantly in creatine treated animals compared to controls (Table 4.6). No significant 
differences in Cu/ZnSOD were observed in CON tissues between creatine treated and 
control animals (Tables 3.5 and 3.6). 
Levels of GPx, which reduces oxidative stress by converting H2O2 and a variety 
of organic peroxides to corresponding stable alcohols and water, showed  
significant decreases in IP hippocampus of animals treated with 1% creatine but not 2% 
(Table 3.5). In IP cortex, GPx also decreased in creatine treated animals compared to 
controls (Table 3.6). 
 Glutathione transferase activities showed a significant increase (p <0.05) in IP 
hippocampus in 2% creatine treated animals compared with controls [F(2,23) = 7.5320, p 
< 0.01] (Table 3.5). In both IP and CON cortex and CON hippocampus, there were no 
significant changes in GST activity between control and creatine treated animals (Tables 
3.5 and 3.6).  
Another antioxidant enzyme, GSSG-R which functions to reduce oxidized GSH 
to reduced GSH as the substrate for the GPx reaction, was significantly (p < 0.05) 
increased in IP cortex of 1% and 2% creatine treated animals relative to controls (Table 
3.6). There were no significant changes in IP or CON hippocampus or CON cortex 
(Tables 3.5 and 3.6). 
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Table 3.5. Antioxidant enzyme activities in hippocampus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IP hippo MnSOD Cu/ZnSOD GPx GSSG-R GST 
control 100.0±25.9 100.0±17.9 100.0±17.3 100.0±11.3 100.0±5.9 
1% creatine 126.8±28.1* 122.8±18.5* 66.3±11.3* 103.2±12.3 106.5±16.2 
2% creatine 127.1±19.7* 121.7±18.2* 86.1±24.3 95.7±11.2 121.0±8.3* 
CON hippo 
control 100.0±34.0 100.0±14.0 100.0±16.4 100.0±10.7 100.0±15.2 
1% creatine 118.6±19.1 115.3±17.0 98.7±18.8 105.4±22.9 95.7±13.7 
2% creatine 130.6±18.5 109.8±9.0 108.7±31.0 97.2±11.0 105.6±15.3 
 
p* < 0.05 compared with control. 
 
Data were expressed as percent of control, mean ± SD 
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Table 3.6. Antioxidant enzyme activities in cortex. 
 
IP cortex MnSOD Cu/ZnSOD GPx GSSG-R GST 
control 100.0±11.0 100.0±15.3 100.0±7.3 100.0±10.3 100.0±9.0 
1% creatine 101.3±27.9 117.2±12.1* 71.8±8.3* 120.2±21.3* 103.6±23.9 
2% creatine 112.6±29.1 126.1±17.0* 71.8±15.1* 122.1±17.9* 102.4±22.5 
CON cortex 
control 100.0±12.9 100.0±16.4 100.0±22.4 100.0±18.4 100.0±18.1 
1% creatine 103.2±18.5 104.7±11.3 108.1±13.1 100.6±16.1 96.6±14.5 
2% creatine 110.3±14.5 96.7±7.7 118.8±57.1 94.7±14.6 103.6±13.3 
 
p* < 0.05 compared with control. 
Data were expressed as percent of control, mean ± SD 
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3.3 Mitochondrial Proteomics 
 Mitochondria function as a signaling center, calcium sink and major ROS source 
in the cell, and previous study showed compromised respiration chain and calcium 
sequestion capacity following TBI. The current study shows increased oxidative damage 
and decreased antioxidant enzyme activities, especially MnSOD, suggesting there could 
be significant changes in mitochondria following TBI. In order to uncover the changes in 
mitochondria, mitochondrial protein levels were evaluated.  
  Isotope-coded affinity tag (ICAT) proteomics is a very efficient method to 
compare protein levels in two different samples. Although most proteomic studies use 2D 
gel electrophoresis, the amount of protein necessary for analysis limits its usefulness 
when only small amounts of protein are available as observed for mitochondria. To 
analyze differences in mitochondrial protein levels the use of ICAT proteomics is the 
most appropriate choice because it only requires 100 μg proteins from each sample for 
analysis. In the current study, using ICAT labeling 2D LC-MS/MS, mitochondrial 
proteins isolated from cortex and hippocampus at 1 h or 24 h post injury were quantified 
to examine individual protein changes. 
3.3.1 Evaluation of  ICAT Labeling for 2D LC-MS/MS 
In this study, ICAT labeling and 2D LC-MS/MS was first evaluated using two 
aliquots of mitochondrial sample from the same pool for heavy and light ICAT reagent 
labeling and MS quantification. Our analyses identified 60 unique proteins of which 
63.3% identified with multiple unique peptides. Most of these proteins (73.3%) were 
mitochondrial based on SwissProt database, which suggest mitochondria were enriched 
by Percoll gradient centrifugation. The mean of heavy to light ratios of all the 
mitochondrial proteins identified from the experiment was 1.06 ± 0.24, showing that the 
ICAT method is reliable to quantify protein expression changes (Table 3.7). However, it 
indicates variations in the methods.  
3.3.2 Proteomic Analysis of Differentially Expressed Mitochondrial Proteins in 
Cortices 1 h and 24 h Post Injury 
 In this study, enriched mitochondria were isolated from IP or CON cortex 
of sham and injured animals 1 and 24 h post injury, and protein expression evaluated 
using ICAT labeling and 2D LC-MS/MS. Tissues were pooled and mitochondria isolated 
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Table 3.7.  Protein identified from one experiment using same sample for heavy and light 
labeling. 
Protein  Name SwissProt Xpress StDev NumPep 
Sodium/potassium-transporting ATPase alpha-
3 chain (P06687) 0.78  1 
Aspartate aminotransferase (P05202) 0.93 0.26 5 
Acyl coenzyme A thioester hydrolase 2 (Q9R0X4) 0.79  1 
Acyl-CoA dehydrogenase family member 9 (Q8JZN5) 0.71 0.66 2 
ADP,ATP carrier protein, heart/skeletal muscle 
isoform T1 (P48962) 1.20 0.18 3 
Sarcoplasmic/endoplasmic reticulum calcium 
ATPase 2 (P11507) 1.02  1 
Sodium/potassium-transporting ATPase beta-1 
chain (P14094) 0.75  1 
ATP synthase alpha chain (Q03265) 0.88 0.22 2 
ATP synthase gamma chain (Q91VR2) 0.91 0.16 10 
ATP synthase D chain (P31399) 1.39 0.54 4 
60 kDa heat shock protein (P19226) 0.82 0.00 2 
Cytochrome c oxidase polypeptide Vb (P19536) 1.14  1 
Cytochrome c oxidase polypeptide VIb (P56391) 1.74 0.85 4 
Calreticulin precursor (P14211) 0.80  1 
Cytochrome c1, heme protein (Q9D0M3) 0.99 0.16 8 
Glutamate dehydrogenase (P26443) 0.77 0.20 8 
Dihydroperidine reductase (P11348) 0.87 0.01 2 
4-aminobutyrate aminotransferase (P61922) 0.95 0.26 7 
Guanine nucleotide-binding protein (P54311) 1.06  1 
Glutaminase, kidney isoform (P13264) 0.97 0.37 8 
Glycerol-3-phosphate dehydrogenase (P35571) 1.04  1 
Hemoglobin beta chain, major-form (P02091) 1.01  1 
Hexokinase, type I (P17710) 0.94 0.21 8 
Isocitrate dehydrogenase [NAD] subunit 
gamma (P70404) 1.04 0.24 4 
cAMP-dependent protein kinase type II-alpha 
chain (P12367) 1.04  1 
Creatine kinase, B chain (Q04447) 1.16  1 
Creatine kinase, ubiquitous mitochondrial (P30275) 1.15 0.18 2 
Hematopoietic stem/progenitor cells protein 
MDS029 homolog (Q91WS0) 1.40 0.42 3 
Malate dehydrogenase (P08249) 1.20 0.40 20 
 
NADH-ubiquinone oxidoreductase B18 
subunit (Q9CR61) 0.86 0.28 3 
NADH-ubiquinone oxidoreductase PDSW 
subunit (Q9DCS9) 1.14 0.39 3 
NADH-ubiquinone oxidoreductase 15 kDa (Q99LY9) 1.21 0.16 2 
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subunit 
NADH-ubiquinone oxidoreductase 75 kDa 
subunit (Q91VD9) 0.96 0.16 4 
NADH-ubiquinone oxidoreductase 24 kDa 
subunit (Q9D6J6) 1.25 - 2 
NADH-ubiquinone oxidoreductase 19 kDa 
subunit (Q9DCJ5) 1.01 0.24 5 
2-Oxoglutarate dehydrogenase E1 component (Q60597) 0.96 0.25 5 
Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate 
    dehydrogenase (P08461) 2.08  1 
Pyruvate dehydrogenase E1 component alpha 
subunit (P35486) 1.54 0.23 4 
Pyruvate dehydrogenase E1 component beta 
subunit (Q9D051) 0.87 0.17 3 
Mitochondrial precursor proteins import 
receptor (Q9CZW5) 1.14  1 
Dynamin-like 120 kDa protein (P58281) 1.10  1 
Proliferation-associated protein 2G4 (P50580) 1.72  1 
Voltage-dependent anion-selective channel 
protein 1 (Q60932) 1.25 0.33 2 
Voltage-dependent anion-selective channel 
protein 3 (Q9R1Z0) 1.02 0.21 10 
Peptidyl-prolyl cis-trans isomerase A (P10111) 1.35  1 
Pyruvate carboxylase (Q05920) 0.78 0.04 2 
Retinoblastoma-like protein 1 (Q64701) 0.78  1 
60S ribosomal protein L18a (P62717) 1.20 0.00 2 
40S ribosomal protein S11 (P62281) 1.30  1 
Sulfated glycoprotein 1 precursor (Q61207) 1.16  1 
Succinyl-CoA ligase [ADP-forming] beta-
chain (Q9Z2I9) 0.97 0.25 3 
Suppressor of cytokine signaling 4 (Q9JLY0) 1.19  1 
Succinate semialdehyde dehydrogenase (P51650) 0.61  1 
Synaptophysin (Q62277) 0.65  1 
Acetyl-CoA acetyltransferase (P17764) 1.60 0.21 2 
Thiosulfate sulfurtransferase (P52196) 1.57 0.49 2 
Ubiquinol-cytochrome-c reductase complex 
core protein 2 (Q9DB77) 1.20 0.26 8 
Ubiquinol-cytochrome C reductase complex 11 
kDa protein (P99028) 1.34 0.21 3 
Hypothetical protein C030036P15Rik (Q8BQM4) 1.30 0.16 3 
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as described labeling and 2D LC-MS/MS. Tissues were pooled and mitochondria isolated 
as described in methods and materials,  and pooled samples were run triplicate to look at 
proteins with prominent changes (Figure 3.13) and reduce variations exist in the current 
method (Yi et al., 2002; Zhang et al., 2005). The results were combined with proteins 
identified in more than two independent experiments for each pool sample, and the 
proteins identified in each pool were combined. A total of 195 proteins were identified in 
this study using quantatitive proteomics, and 37 proteins were identified at each time 
point in both IP and CON tissues (Table 3.8). Fourteen proteins were identified with 
significant changes in at least either IP or CON tissues, or either time point post injury 
(Tables 3.9, 3.10). Major protein classes include those related to oxidative 
phosphorylation, the electron transport chain, and carrier proteins. 
 Several proteins involved in the respiratory chain were identified in our study. In 
complex III, cytochrome c1 was significantly increased (36%, p = 0.0006) 1 h post injury 
in CON cortex, but reduced (27%, p = 0.000) 24 h post injury. Ubiquinol-cytochrome-c 
reductase complex core protein 2 was reduced (31%) as a trend (p = 0.0366) 24 h post 
injury in IP cortex, and slightly but statistically significantly (13%, p = 0.0014) decreased 
in CON cortex at this time point. At 1 h post injury, this complex III core protein 
increased significantly (29%, p = 0.000) in CON cortex. Our data show that cytochrome c 
oxidase polypeptide Vb (cox5b), a component of complex IV, decreased significantly in 
both IP (32%, p = 0.000) and CON (26%, p = 0.000) cortex 24 h post injury. At 1 h post 
injury, cox5b did not change significantly in either IP or CON cortex. Cytochrome c 
oxidase polypeptide VIb (cox6b1), another complex IV subunit, decreased significantly 
24 h post injury in IP (24%, p = 0.000) cortex. 
Analyses of proteins in the TCA cycle show that 2-oxoglutarate dehydrogenase 
E1 component decreased significantly (25%, p = 0.000) in IP cortex 24 h post injury, and 
increased (41%, p = 0.0244) as a trend in CON cortex at 1 h post injury. Dihydrolipoyl 
(dihydrolipoamide) dehydrogenase, a component of the glycine cleavage system as well 
as of the alpha-ketoacid dehydrogenase complexes, decreased (19%) significantly (p = 
0.000) in IP cortex 24 h post injury, and increased (16%, p = 0.0052) as a trend in CON 
cortex 1 h post injury. 
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Figure 3.13. Protein organization. 
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Table 3.8. Proteins identified in both IP and CON cortex at 1 and 24 hour post injury. 
Common name SwissProt 
SwissProt annotated 
location 
biological 
process 
Aspartate aminotransferase P00507 Mitochondrial matrix 
amino acid 
metabolism 
ADP,ATP carrier protein P48962 
Mitochondrial inner 
membrane carrier 
ATP synthase alpha chain Q03265 
Mitochondrial inner 
membrane OXPHOS 
ATP synthase gamma chain Q91VR2 Mitochondrial OXPHOS 
ATP synthase D chain P31399 Mitochondrial OXPHOS 
60 kDa heat shock protein P63038 Mitochondrial matrix 
protein 
import/assembly 
2',3'-cyclic-nucleotide 3'-
phosphodiesterase P16330 membrane cell defense 
Cytochrome c oxidase 
polypeptide Vb, p12075 
Mitochondrial inner 
membrane OXPHOS 
Cytochrome c1, heme protein Q9D0M3 
Mitochondrial 
intermembrane space OXPHOS 
Glutamate dehydrogenase P26443 Mitochondrial matrix TCA cycle 
Dihydrolipoyl dehydrogenase O08749 Mitochondrial matrix 
amino acid 
metabolism 
Glyceraldehyde-3-phosphate 
dehydrogenase Q64467 Cytoplasmic glycolysis 
4-aminobutyrate 
aminotransferase P61922 Mitochondrial matrix 
amino acid 
metabolism 
Glutaminase P13264 Mitochondrial 
amino acid 
metabolism 
Hexokinase, type I P05708 
outer mitochondrial 
membrane glycolysis 
Isocitrate dehydrogenase 
[NAD] subunit gamma P70404 Mitochondrial TCA cycle 
Creatine kinase, B chain Q04447 Cytoplasmic 
energy 
transduction 
Creatine kinase, ubiquitous 
mitochondrial P30275 
Mitochondrial inner 
membrane 
energy 
transduction 
Malate dehydrogenase P04636 Mitochondrial matrix TCA cycle 
NADH-ubiquinone 
oxidoreductase 51 kDa Q91YT0 
Matrix side of 
mitochondrial inner 
membrane OXPHOS 
NADH-ubiquinone 
oxidoreductase 13 kDa P52504 
Mitochondrial inner 
membrane OXPHOS 
Alpha-ketoglutarate 
dehydrogenase Q60597 Mitochondrial matrix TCA cycle 
Ubiquinol-cytochrome-c 
reductase complex Q9DB77 
Mitochondrial inner 
membrane OXPHOS 
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       core protein 2 
Ubiquinol-cytochrome C 
reductase complex 11 kDa 
protein P99028 
Mitochondrial inner 
membrane OXPHOS 
Sodium/potassium-transporting 
ATPase alpha-1 chain 
precursor Q8VDN2 
Integral membrane 
protein transport 
Sodium/potassium-transporting 
ATPase alpha-3 chain Q6PIC6 
Integral membrane 
protein transport 
Calcium-binding mitochondrial 
carrier protein Aralar1 Q8BH59 
Mitochondrial inner 
membrane transport 
Cytochrome c oxidase 
polypeptide VIb  P56391 Mitochondrial OXPHOS 
Mitochondrial glutamate 
carrier 1 Q9D6M3 
Mitochondrial inner 
membrane transport 
Uncharacterized hematopoietic 
stem/progenitor call protein 
MDs029 homolog Q91ws0 unknown unknown 
NADH-ubiquinone 
oxidoreductase 19 kDa      
subunit Q9DCJ5 Mitochondrial OXPHOS 
Voltage-dependent anion-
selective channel protein 1 
(VDAC-1) Q60932 
outer membrane of 
mitochondria channels 
Voltage-dependent anion-
selective channel protein 3 
(VDAC-3) Q9R1Z0 
Outer mitochondrial 
membrane channels 
Syntaxin binding protein 1 
(Unc-18 homolog) O08599 
Cytoplasmic, 
peripheral membrane 
protein signaling 
Synaptophysin Q62277 
Integral membrane 
protein signaling 
Tubulin beta-3 Q9ERD7 cytoskeleton structure 
Tubulin beta-4 chain Q9D6F9 cytoskeleton structure 
Note: each protein was identified in at least two experiments at each time point in CON 
and IP cortices. 
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Table 3. 9. Cortical mitochondrial proteins. 
 1h IP 24h IP 
protein ratio p ratio p 
Cytochrome c1, heme 
protein 1.08 ± 0.20 0.4778 0.73 ± 0.08 0.000 
Ubiquinol-cytochrome-c 
reductase complex core 
protein 2 
0.92 ± 0.1 0.238 0.69 ± 0.21 0.0366 
Cytochrome c oxidase 
polypeptide Vb 1.03 ± 0.31 0.865 0.68 ± 0.11 0.000 
Cytochrome c oxidase 
polypeptide VIb 0.87 ± 0.18 0.3174 0.76 ± 0.05 0.000 
Dihydrolipoyl 
dehydrogenase 1.05 ± 0.09 0.3844 0.81 ± 0.08 0.000 
Alpha-ketoglutarate 
dehydrogenase 1.08 ± 0.23 0.617 0.75 ± 0.07 0.000 
Hexokinase, type I 1.00 ± 0.03 0.9362 0.82 ± 0.06 0.000 
Glyceraldehyde-3-
phosphate dehydrogenase 1.24 ± 0.37 0.3574 2.02 ± 0.67 0.0316 
Creatine kinase, 
ubiquitous mitochondrial 1.07 ± 0.25 0.617 3.62 ± 3.87 0.242 
ANT1 1.42 ± 0.04 0.000 2.18 ± 1.95 0.3954 
Aralar1 1.11 ± 0.43 0.7338 0.71 ± 0.21 0.0524 
Mitochondrial glutamate 
carrier 1 1.12 ± 0.47 0.660 0.72 ± 0.23 0.097 
VDAC1 1.31 ± 0.41 0.190 0.80 ± 0.11 0.001 
VDAC3 1.04 ± 0.30 0.8494 0.80 ± 0.03 0.000 
Data were expressed as mean ± SD. 
 84
Table 3. 10. Cortical mitochondrial proteins. 
 1h CON 24h CON 
protein ratio p ratio p 
Cytochrome c1, heme 
protein 1.36 ± 0.18 0.0006 0.92 ± 0.22 0.5352 
Ubiquinol-cytochrome-c 
reductase complex core 
protein 2 
1.29 ± 0.01 0.000 0.87 ± 0.06 0.0014 
Cytochrome c oxidase 
polypeptide Vb 1.23 ± 0.20 0.1586 0.74 ± 0.10 0.000 
Cytochrome c oxidase 
polypeptide VIb 1.02 ± 0.22 0.8494 0.80 ± 0.43 0.5156 
Dihydrolipoyl 
dehydrogenase 1.16 ± 0.10 0.0052 1.03 ± 0.29 0.8572 
Alpha-ketoglutarate 
dehydrogenase 1.41 ± 0.26 0.0244 0.94 ± 0.39 0.7794 
Hexokinase, type I 1.43 ± 0.64 0.2984 0.91 ± 0.17 0.3788 
Glyceraldehyde-3-
phosphate dehydrogenase 0.90 ± 0.05 0.0028 0.91 ± 0.03 0.000 
Creatine kinase, ubiquitous 
mitochondrial 1.24 ± 0.03 0.000 0.91 ± 0.17 0.2584 
ANT1 1.29 ± 0.35 0.246 0.93 ± 0.07 0.1528 
Aralar1 1.26 ± 0.09 0.000 1.10 ± 0.42 0.6818 
Mitochondrial glutamate 
carrier 1 1.62 ± 0.08 0.000 0.94 ± 0.08 0.3174 
VDAC1 1.05 ± 0.15 0.5286 0.96 ± 0.16 0.6242 
VDAC3 1.30 ± 0.25 0.0854 1.09 ± 0.12 0.2006 
Data were expressed as mean ± SD. 
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Our analysis also identified several proteins involved in glycolysis, NADH 
transport and mitochondrial transition pore (MTP) formation. Glyceraldehyde-3-
phosphate dehydrogenase functions in glycolysis and apoptosis, and was increased in IP 
cortex 24 h post injury as a trend, and decreased significantly in CON cortex at 1 (10%, p 
= 0.0028) and 24 h (9%, p = 0.000) post injury respectively. Hexokinase 1, a component 
of glycolysis and MTP formation, decreased significantly (18%, p = 0.000) in IP cortex 
24 h post injury, but did not change significantly in CON cortex 1 and 24 h post injury, or 
in IP cortex  at 1 h post injury. Creatine kinase is involved in energy transport and MTP 
formation, and was increased significantly (24%, p = 0.000) 1 h post injury in CON 
cortex. Carrier proteins, aralar1 and cintrin were increased significantly (26%, p = 0.000 
and 62%, p = 0.000, respectively) 1 h post injury in CON cortex, and decreased as a trend 
(29%, p = 0.0524 and 28%, p = 0.097, respectively) 24 h post injury in IP cortex. 
ADP/ATP carrier protein increased (42%) significantly (p = 0.000) 1 h post injury in IP 
cortex. VDAC proteins (VDAC1 and VDAC3), channel proteins for metabolite exchange 
across outer membrane and members of the MTP, decreased significantly (p = 0.001 for 
VDAC1 and p = 0.000 for VDAC3) in IP cortex 24 h post injury (Table 3.9). 
3.3.3 Proteomic Analysis of Differentially Expressed Mitochondrial Proteins in 
Hippocampi 1 h and 24 h Post Injury 
 In this study, enriched mitochondria were isolated from IP and CON hippocampus 
of sham and injured animals 1 and 24 h post injury and were processed as described 
above. Mitochondrial proteins from four independent samples were pooled again, and 
samples from each pool were run in triplicate to examine proteins with prominent 
changes. A total of 29 proteins were identified at each time point in both IP and CON 
tissues (Table 3.11). Twenty proteins were identified with significant changes in either IP 
or CON tissues, at either time point post injury (Tables 3.12, 3.13). Major classes include 
those related to oxidative phosphorylation and transport. 
 Several proteins involved in the respiratory chain were identified in this study. 
NADH-ubiquinone oxidoreductase B18 subunit, a component of complex I, was 
significantly decreased (30%, p = 0.0025) in IP hippocampus but significantly increased 
26% (p = 0.0012) in CON hippocampus 24 h post injury. Cytochrome c1, a component of 
complex III, was increased (26%) as a trend (p = 0.0078) in CON hippocampus 24 h post
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Table 3. 11. Proteins identified in both IP and CON hippocampus at 1 and 24 hour post 
injury. 
 
Common name SwissProt
SwissProt annotated 
location 
Biological 
process 
Calcium\calmodulin-
dependent protein kinase 
type II  alpha chain p11275 postsynaptic lipid rafts signaling 
Synaptophysin p07825 integral membrane protein signaling 
Sodium\potassium-
transporting ATPase alpha-3 
     chain P06687 membrane protein transport 
Tubulin beta-5 chain P69897 cytoskeleton structure 
Tubulin alpha-2 chain Q6P9V9 cytoskeleton structure 
2',3'-cyclic-nucleotide 3'-
phosphodiesterase P13233 membrane cell defense 
Mitochondrial glutamate 
carrier 1 Q9D6M3 
mitochondrial inner 
membrane transport 
Aspartate aminotransferase P00507 mitochondrial matrix 
amino acid 
metabolism 
Glutamate dehydrogenase 1 P10860 mitochondrial matrix TCA cycle 
Voltage-dependent anion-
selective channel protein 3 Q9R1Z0 
mitochondrial outer 
membrane channels 
60 kDa heat shock protein, 
mitochondrial precursor P63039 mitochondrial matrix 
protein import 
and assembly 
ATP synthase gamma chain P35435 mitochondrial OXPHOS 
Malate dehydrogenase P04636 mitochondrial matrix TCA cycle 
Voltage-dependent anion-
selective channel protein 1 Q9Z2L0 
mitochondrial outer 
membrane channels 
Creatine kinase, ubiquitous 
mitochondrial precursor P30275 
mitochondrial inner 
membrane 
energy 
transduction 
Ubiquinol-cytochrome c 
reductase complex 11 kDa  
     protein P99028 
mitochondrial inner 
membrane OXPHOS 
Citrate synthase Q9CZU6 mitochondrial matrix TCA cycle 
Isocitrate dehydrogenase 
[NAD] subunit alpha Q9D6R2 mitochondrion TCA cycle 
Dihydrolipoyl 
dehydrogenase Q6P6R2 mitochondrial matrix 
amino acid 
metabolism 
Aconitate hydratase Q9ER34 mitochondrion TCA cycle 
ATP synthase subunit alpha P15999 
mitochondrial inner 
membrane OXPHOS 
Hexokinase-1 P05708 
outer mitochondrial 
membrane glycolysis 
Ubiquinol-cytochrome-c 
reductase complex core  P32551 
mitochondrial inner 
membrane; matrix side OXPHOS 
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     protein 2 
ADP\ATP translocase 1 P48962 
mitochondrial inner 
membrane transport 
Cytochrome c1, heme 
protein Q9D0M3 
mitochondrial 
intermembrane space OXPHOS 
Mitochondrial precursor 
proteins import receptor Q9CZW5 
mitochondrial outer 
membrane receptor 
NADH-ubiquinone 
oxidoreductase B18 subunit Q9CR61 
mitochondrial inner 
membrane OXPHOS 
Excitatory amino acid 
transporter 2 P43006 Membrane transport 
Calcium-binding 
mitochondrial carrier protein 
aralar1 Q8BH59 
mitochondrial inner 
membrane transport 
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Table 3. 12. Hippocampal mitochondrial proteins 
 1h IP 24h IP 
protein ratio p ratio p 
NADH-ubiquinone 
oxidoreductase B18 subunit 0.90 ± 0.35 0.6892 0.70 ± 0.17 0.0025 
Ubiquinol-cytochrome-c 
reductase core protein 2 0.92 ± 0.12 0.3174 1.33 ± 0.01 0.000 
Cytochrome c1, heme protein 1.06 ± 0.12 0.4066 1.04 ± 0.15 0.6672 
Ubiquinol-cytochrome c 
reductase 11 kDa protein 1.01 ± 0.0.1 0.8886 1.28 ± 0.01 0.000 
ATP synthase gamma chain 0.85 ± 0.08 0.0016 0.94 ± 0.24 0.6672 
ATP synthase subunit alpha 1.07 ± 0.06 0.0818 0.87 ± 0.25 0.3734 
Aspartate aminotransferase 1.03 ± 0.07 0.5092 1.37 ± 0.36 0.0718 
Glutamate dehydrogenase 1 1.09 ± 0.53 0.3222 1.20 ± 0.04 0.000 
Malate dehydrogenase 0.90 ± 0.05 0.0002 1.22 ± 0.36 0.2938 
Citrate synthase 1.02 ± 0.15 0.8886 1.39 ± 0.10 0.000 
Isocitrate dehydrogenase subunit 
α 0.97 ± 0.13 0.7434 1.14 ± 0.45 0.5824 
Dihydrolipoyl dehydrogenase 1.05 ± 0.14 0.6384 1.36 ± 0.19 0.0088 
Hexokinase-1 0.76 ± 0.05 0.000 0.99 ± 0.33 0.9442 
ADP\ATP translocase ANT1 0.84 ± 0.06 0.000 1.24 ± 0.15 0.0258 
Mitochondrial precursor proteins 
import receptor (TOM70) 0.98 ± 0.11 0.8026 1.13 ± 0.16 0.2380 
Aralar1 0.86 ± 0.07 0.0008 1.14 ± 0.20 0.9680 
VDAC1 0.90 ± 0.04 0.000 1.06 ± 0.02 0.000 
VDAC3 0.80 ± 0.11 0.0124 1.01 ± 0.12 0.9522 
60 kDa heat shock protein 1.03 ± 0.1 0.603 1.27 ± 0.18 0.0384 
Data were expressed as mean ± SD. 
 89
Table 3. 13. Hippocampal mitochondrial proteins 
 1h CON 24h CON 
protein ratio p ratio p 
NADH-ubiquinone 
oxidoreductase B18 subunit 0.97 ± 0.16 0.7872 1.26 ± 0.14 0.0012
Ubiquinol-cytochrome-c 
reductase core protein 2 1.19 ± 0.28 0.3422 1.34 ± 0.69 0.4902
Cytochrome c1, heme protein 1.02 ± 0.11 0.7872 1.26 ± 0.17 0.0078
Ubiquinol-cytochrome c 
reductase 11 kDa protein 1.07 ± 0.20 0.5156 1.54 ± 0.83 0.2584
ATP synthase gamma chain 0.96 ± 0.05 0.1646 1.28 ± 0.12 0.000 
ATP synthase subunit alpha 0.87 ± 0.02 0.000 1.23 ± 0.28 0.147 
Aspartate aminotransferase 0.99 ± 0.06 0.8572 1.64 ± 0.30 0.0002
Glutamate dehydrogenase 1 0.95 ± 0.07 0.215 1.12 ± 0.14 0.2802
Malate dehydrogenase 0.95 ± 0.06 0.1556 1.48 ± 0.25 0.0008
Citrate synthase 1.12 ± 0.18 0.3576 1.60 ± 0.45 0.0602
Isocitrate dehydrogenase subunit 
α 1.14 ± 0.05 0.000 1.37 ± 0.15 0.000 
Dihydrolipoyl dehydrogenase 1.08 ± 0.29 0.6528 1.81 ± 1.28 0.2758
Hexokinase-1 0.97 ± 0.01 0.000 1.27 ± 0.22 0.034 
ADP\ATP translocase ANT1 1.04 ± 0.11 0.5418 1.65 ± 0.33 0.0006
Mitochondrial precursor proteins 
import receptor (TOM70) 1.28 ± 0.06 0.000 1.17 ± 0.30 0.3222
Aralar1 0.85 ± 0.14 0.0026 1.09 ± 0.06 0.025 
VDAC1 0.99 ± 0.24 0.9602 1.29 ± 0.44 0.246 
VDAC3 1.21 ± 0.15 0.0512 1.51 ± 0.08 0.000 
60 kDa heat shock protein 0.93 ± 0.04 0.0022 1.40 ± 0.16 0.000 
Data were expressed as mean ± SD. 
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injury. Ubiquinol-cytochrome-c reductase complex core protein 2 was significantly (p = 
0.000) increased 33% in IP hippocampus 24 h post injury. Levels of ubiquinol-
cytochrome C reductase complex 11 kDa protein were increased (28%) significantly (p = 
0.000) in IP hippocampus at 24 h post injury. ATP synthase gamma chain, a component 
of complex V, significantly decreased (p = 0.0016) in IP hippocampus at 1 h post injury. 
It increased (p = 0.000) in CON hippocampus at 24 h post injury. ATP synthase subunit 
alpha decreased (13%) significantly (p = 0.000) in CON hippocampus 1 h post injury. 
 Analysis of TCA cycle proteins show that glutamate dehydrogenase increased 
(20%) significantly (p = 0.000) 24 h post injury in IP hippocampus, and isocitrate 
dehydrogenase [NAD] subunit alpha increased significantly in CON hippocampus at 1 h 
(14%, p = 0.000) and 24 h (37%, p = 0.000) post injury. Citrate synthase significantly 
increased 39% (p = 0.000) 24 h post injury in IP hippocampus. Aconitate hydratase 
significantly increased 45% (p = 0.002) in CON hippocampus 24 h post injury. Malate 
dehydrogenase significantly increased 48% (p = 0.0008) 24 h post injury in CON 
hippocampus and deceased 10% (p = 0.0002) in IP hippocampus 1 h post injury. 
Dihydrolipoyl (dihydrolipoamide) dehydrogenase, a component of the glycine cleavage 
system as well as of the alpha-ketoacid dehydrogenase complexes, increased 36% as a 
trend (p = 0.0088) in IP hippocampus 24 h post injury. Aspartate aminotransferase, 
another enzyme thought to be expressed in liver and heart, was identified in the 
mitochondrial sample, and increased significantly (p = 0.0002) in CON (64%) 
hippocampus 24 h post injury. This enzyme is also involved in metabolism by catalyzing 
oxaloacete related reaction. 
 Our study also identified proteins involved in glycolysis, protein transport and 
folding, and the mitochondrial transition pore (MTP). Hexokinase 1, a member of the 
glycolytic pathway and MTP formation, decreased (24%) significantly (p = 0.000) in IP 
hippocampus 1 h post injury, and increased (27%) as a trend (p = 0.034) in CON 
hippocampus 24 h post injury. A carrier protein, ANT1, increased 24% (p = 0.0258) in IP 
hippocampus and 65% (p = 0.0006) in CON hippocampus 24 h post injury, and decreased 
significantly (p = 0.000) in IP hippocampus 1 h post injury. Aralar 1 decreased 
significantly  at 1 h post injury in IP(p = 0.0008) and CON (p = 0.0026) hippocampus. 
Mitochondrial precursor protein importer receptor TOM70 increased significantly (p = 
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0.000) 1 h post injury in CON hippocampus. VDAC1 and VDAC3 are involved in outer 
membrane permeability. Our data showed that VDAC1 significantly decreased 10% (p = 
0.000) in IP hippocampus 1 h post injury but increased (6%) significantly in IP 
hippocampus 24 h post injury. VDAC3 decreased (20%) as a trend (p = 0.0124) 1 h post 
injury in IP hippocampus, but increased significantly (p = 0.000) in CON hippocampus 
24 h (51%) post injury. Heat shock protein, HSP60, increased in IP (27%) as a trend (p = 
0.0384) and significantly increased (p = 0.000) in CON (40%) hippocampus 24 h post 
injury.  
3.3.4 Validation of VDAC and Hexokinase 1 with Western Blot Analyses 
Proteomic analysis identified proteins with expression changes following TBI. In 
order to validate proteomic identification, VDAC and hexokinase 1 protein expressions 
were quantified by Western blot analysis. Our data showed that VDAC expression 
significantly (p < 0.05) decreased in IP cortex 24 h post injury, with 20% decrease 
compared to sham animals (Figure 3.14). HK1 expression also significantly (p < 0.05) 
decreased in IP cortex compared to sham (Figure 3.15). The ratio of protein expression 
from Western blot is comparable to those observed from proteomics using ICAT labeling 
and 2D LC/MS/MS. As the three independent samples were used in western blot, our 
data indicate the proteomics method using pooled samples is effective to determine 
proteins with prominent changes following TBI. 
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Figure 3.14. Western blot analysis of VDAC protein levels in IP cortex (panel A) and 
CON cortex (panel C). There is a significant (p < 0.05) time dependent decrease in 
VDAC in IP cortex (panel B), but no significant change in CON cortex (panel D). 
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Figure 3.15. Western blot analysis of hexokinase in IP cortex (panel A) and CON cortex 
(panel C). There is a statistically significant (p < 0.05) time dependent decrease in HK1 
levels in IP cortex compared to sham cortex (panel B). There were no significant 
differences in HK1 in CON cortex (panel D). 
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Chapter Four 
Discussion 
4.1 Reduced Tissue Sparing in TBI in Aging 
Aging is associated with increased mortality rates and neurological deficits 
following TBI, but the mechanism is not well understood (Teasdale et al., 1979; Hamm et 
al., 1991; Hamm et al., 1992; Klein et al., 1996; Maughan et al., 2000; Hoane et al., 
2004). Previous studies show traumatic brain injury results in delayed dysfunction and 
death of neuron populations near and distant to the site of injury through secondary 
processes (Cooper, 1985). Neuron death can lead to tissue shrinkage or loss. In an aging 
study, Hoane et al. (Hoane et al., 2004) showed that middle aged animals suffered more 
tissue loss than young animals after TBI, although aged animals were not investigated in 
their study. The current data described in this dissertation show middle aged and aged 
animals both experience significant tissue loss compared to young animals with no 
significant difference between middle aged and aged animals 7 days post injury. More 
brain tissue loss indicates more severe damage to the brain, and could lead to more 
problems following injury. So the current result may explain why aged animals have 
increased mortality rate than young adult animals, but does not provide insight into the 
differences between middle-aged and aged animals. To further investigate effects of age 
in TBI, further studies are required to evaluate the changes of brain in aging in TBI.  
4.2 Oxidative Stress in Head Trauma in Aging 
Oxidative damage is suggested to be an important factor for neurological deficits 
(Camandola et al., 2000; Anderson et al., 2005; Hall et al., 2005) following TBI, and is 
also hypothesized to play a role in diminished recovery from TBI in aged subjects. The 
oxidative damage is initiated by increased ROS in cell. There are several sources for ROS 
in cell, and mitochondria are believed to be major source following TBI. ROS can cause 
oxidative damage to biological macromolecules, including peroxidation of membrane 
polyunsaturated fatty acids (PUFA) (McCall et al., 1987; Beckman et al., 1993; Hall et 
al., 2004) and DNA (Johnson et al., 2005; Wang et al., 2005). PUFA peroxidation 
ultimately leads to loss of both structural and functional integrity of the cell with 
generation of toxic aldehydic by-products, such as HNE and acrolein (Uchida and 
Stadtman, 1994), which may further contribute to neuronal cell death by protein and 
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DNA modification (Graham et al., 1978). DNA oxidation and modification by aldehydes 
may lead to gene mutation and affect transcription (Barzilai and Yamamoto, 2004; 
Shimamura et al., 2004). 
In the current study, in order to look at changes in cortex and hippocampus in TBI 
in aging except for tissue loss, the markers of oxidative damage, HNE, acrolein, and 
oxidized DNA bases, were investigated at 24 h or 7 days post injury. The oxidative 
damage 24 h post injury could show changes in neurons before cell death, and the 
damage at 7 days post injury could show the neuron damage even it survived at this time 
point. So the study at this two time point provided an early and late response of neuronal 
cell in cortex and hippocampus to TBI. 
4.2.1 Lipid Peroxidation in TBI in Aging 
There have been few studies of markers of oxidative stress or antioxidant 
capacities following TBI in aged animals (Wagner et al., 2004). The present study 
demonstrates age dependent increased lipid peroxidation 1 and 7 days following TBI. To 
minimize biological variation among animals, CON tissues of injured animals were used 
as control to investigate the changes in IP tissues. The data described in this dissertation 
show there were no significant differences in HNE or acrolein levels between CON 
tissues of injured animals and CON and IP tissues of sham animals. Previous studies also 
show distal tissues in CCI model showed no significant response in oxidative damage 
(DeKosky et al., 2004). In comparison of levels of lipid peroxidation in tissues isolated 
before and after in skull flash-freezing showed no artifactual oxidation occurring during 
the time between cervical dislocation and tissue extraction. 
In cortical TBI, the hippocampus suffers significant neuronal loss immediately 
after injury that increases for up to seven days post injury, which may contribute to 
memory deficit. Using immunohistochemistry Wang et al. (Wang et al., 2003) showed 
HNE levels increased following TBI in IP hippocampus in young animals. Using dot blot 
immunochemistry, we showed HNE levels increased significantly in IP hippocampus 24 
h post injury in each age group, suggesting pronounced lipid peroxidation and protein 
modification at this time point. The intensive oxidative damage could lead to delayed 
neuron death in IP hippocampus. Acrolein, another neurotoxic marker of lipid 
peroxidation, showed a similar trend as HNE with aged animals showing higher levels in 
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IP hippocampus compared to CON hippocampus. At 7 days post injury, levels of HNE 
and acrolein in IP hippocampus were reduced to CON hippocampal levels in young 
animals. This phenomenon may indicated young animals are able to reduce oxidative 
damage by its own defense. Although middle aged animals also showed reduced levels of 
HNE and acrolein compared to 24 h post injury, the levels were elevated compared to 
contralateral hippocampus. Levels of HNE remained elevated in aged animals at 7 days 
post injury. The increased oxidative damage following TBI could lead to mitochondrial 
dysfunction (Lifshitz et al., 2003) and diminished neuron recovery following TBI. The 
age dependent oxidative damage in hippocampus may help explain increased functional 
deficit following TBI in aged subjects. 
In cortex, primary mechanical brain injury causes subdural hematoma, laceration, 
diffuse vascular injury, and cell death in the impact zone that involves extensively 
complicated processes (BIROS, 1998b; Raghupathi, 2004). ROS generation in cortex of 
young animals following TBI increases with time in early stages (Hall et al., 1993; Smith 
et al., 1994; Nishio et al., 1997). In addition, documented studies show lipid peroxidation 
products significantly increase immediately following injury, and remain elevated for 
several days in young animals (Hall et al., 2004). HNE levels increased in IP cortex in 
each age group at 24 h post injury, but did not show age dependent differences. At 7 days 
post injury, HNE levels decreased in IP cortex in young animals, but kept increasing in 
middle aged animals. Aged animals did not show more oxidative damage 7 days post 
injury compared to 24 h post injury. Unlike oxidative damage in hippocampus, there is no 
clear age dependent change in cortical lipid peroxidation, especially at 24 h post injury. 
Hall et al. (1993) reported that a major source of ROS is microvasculature, and saline 
perfusion of the injured mice eliminated ROS levels measured in their study (Hall et al., 
1993). Blood is enriched by iron from hemoglobin. The free iron catalyzes the formation 
of ROS by Fenton’s reaction and could lead to increase of lipid peroxidation. The cortex 
samples harvested following TBI were bloody in the current study, so it is possible that 
blood in the cortex tissues led to significant lipid peroxidation and masked the difference 
in lipid peroxidation in aging in our study. 
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4.2.2 DNA Oxidation in TBI in Aging 
As discussed above, oxidative stress plays a pivotal role in TBI in aging. 
Mitochondria are major sources of superoxide radicals especially following 
mitochondrial dysfunction (Xiong et al., 1997b; Sullivan et al., 2002; Lifshitz et al., 
2003). Superoxide can be converted to hydrogen peroxide by superoxide dismutase 
(SOD) (Fridovich, 1997). Hydrogen peroxide is further transformed to water through 
glutathione peroxidase. However, it can potentially interact with transition metals to form 
hydroxyl radicals that are significantly increased following TBI (Smith et al., 1994). 
Hydroxyl radicals can attack nucleic acids, and lead to oxidative damage (Rehman et al., 
1999). More than 20 oxidized DNA bases have been identified (Candeias and Steenken, 
2000; Evans et al., 2004), of these 8-hydroxyguanine is the most studied because it is the 
predominant marker of DNA damage (Pratviel and Meunier, 2006). Fapyguanine, 8-
hydroxyadenine, fapyadenine, and 5-hydroxycytosine are other products of guanine, 
adenine and cytosine oxidative damage. In order to further evaluate oxidative damage in 
TBI in aging, we quantified five DNA base oxidation products to quantify the different 
oxidative response in aging. For this study, GC/MS-SIM was used because it can monitor 
multiple bases simultaneously in a single run (Dizdaroglu, 1990).  
 Previous studies showed increased 8-hydroxyguanine (8-OHG) levels in rat 
cortex 15 min post injury using immunohistochemistry (Mendez et al., 2004) in young 
animals. Our present study using GC/MS-SIM showed 8-OHG levels were increased as a 
trend but not statistically significant in IP cortex of injured and sham animals compared 
with their CON cortex. No significant differences were observed between injured and 
sham animals 24 h post injury. Additionally, no significant differences were observed in 
8-OHG levels in middle aged IP or CON cortex between injured and sham animals. In 
contrast, aged animals showed 8-OHG levels significantly increased in IP cortex of 
injured animals compared with their CON cortex and with sham animals. Moreover, 8-
OHG levels were significantly higher in IP cortex of aged animals compared to young 
and middle aged animals, suggesting an age dependent increase of oxidative damage. Our 
lipid peroxidation study in TBI in aging showed lipid peroxidation was significantly 
increased in young, middle aged and aged animals in cortex 24 h post injury (Shao et al., 
2006). The differences in lipid peroxidation and DNA damage in young and middle aged 
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animals suggest lipid damage increases more rapidly than DNA damage. In aged animals, 
severe oxidative damage can lead to both DNA and lipid oxidation. In hippocampus, 
extensive DNA damage was observed even though it is subjected to less mechanical 
injury compared to cortex. Our data suggest an age dependent increase of DNA damage 
with significant elevations of 8-OHG in injured IP hippocampus of middle aged and aged 
animals compared with young animals. In addition, 8-OHG levels in IP hippocampus in 
middle aged and aged animals were significantly increased compared to CON 
hippocampi. These data are consistent with our previous study of lipid peroxidation in 
TBI in aging (Shao et al., 2006). The presence of increased levels of DNA base adducts 
and lipid peroxidation byproducts in aged animals may help explain why aged animals 
exhibit increased neuron and memory loss following TBI (Ward et al., 1999). DNA 
damage may be particularly problematic because it can lead to alterations in transcription 
through a G:C to T:A mutation (Barzilai and Yamamoto, 2004), and changes in gene 
expression (Shimamura et al., 2004). Although DNA repair in nuclei can be mediated by 
MutT homolog (MTH1), MutT or oxoguanine glycosylase (OGG1) (Nakabeppu et al., 
2004), extensive ROS may overwhelm the repair capacity. Although fapyguanine, 8-
hydroxyadenine, fapyadenine, and 5-hydroxycytosine levels were not significantly 
different in aging in TBI, there was a trend toward increased levels of these oxidized 
bases in aging.  
4.2.3 Antioxidant Enzyme Activities in TBI in Aging 
Previous studies that secondary oxidative damage can regulate gene expression 
and inflammatory response in the hippocampus, especially in genes related to metabolism 
and antioxidant enzymes (Long et al., 2003). However, proteins are the units that 
function directly in cell defense, and gene transcription change may not necessarily 
reflect antioxidant enzyme defense capacity since oxidative damage may inactivate 
enzymes following TBI. In order to quantify cellular defense capacities, protein activity 
is most direct measure for the study. There are several antioxidant enzymes in neurons 
that decrease oxidative stress, including Cu/ZnSOD, MnSOD, catalase, GPx, GSSG-R, 
and GST. Although these enzymes work in concert to protect the cell, cell death can 
result if ROS production exceeds the defense capacity. We hypothesize that oxidative 
 99
damage, lipid peroxidation and DNA oxidation, following TBI and the differences in 
oxidative damage in TBI in aging may result from deficits in antioxidant capacities. 
Superoxide dismutases function to convert superoxide ion to less active hydrogen 
peroxide and avoid the formation of further ROS, and have been widely investigated in 
neurodegenerative diseases. Transgenic mice overexpressing SOD showed increased 
tissue sparing and improved neurological function compared with their WT littermates 
following TBI (Maier and Chan, 2002). In addition, Dekosky et al (DeKosky et al., 2004) 
reported that SOD activity decreased significantly 6 h after TBI and 20% of activity was 
lost 24 h and 30% lost 7 days post injury in young rats subjected to severe injury in the 
anterior hippocampus.  Our data failed to show a significant age-dependent change in 
Cu/ZnSOD activity for any age or time point studied. Although MnSOD does not change 
significantly in young and middle aged animals 24 h post injury, it decreased 
significantly (20%) in aged animals compared to middle aged animals. In contrast to the 
study of Dekosky et al. (DeKosky et al., 2004), we did not observe significant losses of 
SOD even 7 days post injury in young animals. However, we observed a 30% loss in IP 
hippocampus MnSOD activity in middle aged and aged animals. Statistical analysis 
showed an age-dependent decrease of MnSOD activity in aging. The decrease of the 
mitochondrial MnSOD could compromise the cell’s ability to remove superoxide 
generated after the TBI and lead to mitochondrial damage (Xiong et al., 2005), increased 
lipid peroxidation (Awasthi et al., 1997), and DNA damage, which could lead to cell 
apoptosis and result in neuron loss  and cognitive deficits in older animals. 
In the antioxidant defense system, glutathione peroxidase follows SOD and 
reduces hydrogen peroxide to water with consumption of glutathione. Table 2 shows that 
GPx increased in young IP hippocampus 1 and 7 days post injury with little change in 
middle aged or aged animals. The current data in this dissertation show a significant age 
dependent decrease of GPx activity observed 24 h post injury in middle aged and aged 
animals compared to young animals. At 7 days post injury, GPx activities were lower in 
middle aged and aged IP hippocampus compared with young IP hippocampus, although 
the differences did not reach statistical significance. These data are consistent with those 
of Dekosky et al. (DeKosky et al., 2004) who showed increased GPx activity in 
hippocampus in young TBI animals 7 days post injury.  Our data further show that GPx 
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protein expression increased significantly (data not shown) in IP cortex and 
hippocampus, which is consistent with the theory that this enzyme is upregulated by 
oxidative stress (Baud et al., 2004). However, higher abundance of this enzyme did not 
improve neuron antioxidant capacity in middle aged and aged animals. Young animals 
showed elevated GPx activities compared with older animals that may help limit further 
oxidative damage. 
Previous studies show GST overexpression is neuroprotective in cell culture (Xie 
et al., 2001). Glutathione transferase can alleviate damage from lipid peroxidation by-
products (HNE and acrolein) by catalyzing their conjugation with glutathione (GSH). 
GST depletion could result in increased protein modification and lead to more protein 
dysfunction, which could contribute to further oxidative damage. Our data show 
significant GST activity loss in IP hippocampus 7 days post injury for middle aged and 
aged animals, but not for young animals. However, there is no significant difference in 
aging in IP hippocampus. Glutathione reductase, which functions to regenerate reduced 
glutathione, has been studied in neurodegenerative disease (Lovell et al., 1995), but not in 
traumatic brain injury. Our study shows a significant decrease in GSSR-R in middle aged 
and aged IP hippocampi at 7 days post injury, but not for young animals.  
Antioxidant enzyme activities have not been studied in cortex in TBI even though 
oxidative stress has been well documented in the last several decades. Our data show 
MnSOD in IP cortex was depleted in an age dependent manner 24 h post injury and that 
the decrease correlated with increased tissue loss. Diminished antioxidant activity may 
compromise defense capacities against oxidative stress (Azbill et al., 1997), and may 
contribute to neuron death in the impact zone. At 7 days post injury, MnSOD activity in 
IP cortex significantly decreased in young, middle aged and aged animals, but did not 
show an age dependent difference. Activities of Cu/ZnSOD were decreased in IP cortex 
of all three age groups 7 days post injury, but they did not show significant age dependent 
differences. GPx activity did not change significantly 24 h post injury in any age group 
studied, although young and middle aged animals showed increased activity as a trend at 
7 days post injury. There were no age dependent differences at any time point for this 
antioxidant enzyme. GST activity decreased 24 h post injury in IP cortex in each age 
group with more pronounced decreases occurring in middle aged animals 7 days post 
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injury. GST depletion in cortex may result in intensive biochemical modification of 
biomolecules by toxic aldehydic byproducts from lipid peroxidation, suggesting middle 
aged animals may suffer further damage. GSSG-R decreased significantly in middle aged 
and aged IP cortex compared to young animals 24 h post injury, although no significant 
differences were observed 7 days post injury. GSSR-R depletion 24 h post injury could 
contribute to depletion of glutathione, a critical low molecular weight (LMW) 
antioxidant, and contribute to cell death and tissue loss in later days. 
4.3 Mitochondrial Proteomics in TBI 
In TBI, there was significant tissue loss in injured cortex 1 week post injury, but 
not at 24 hours post injury. However, there is significant oxidative damage at 24 h post 
injury, showing increased HNE, acrolein, and oxidized DNA bases. The oxidative 
damage in neuron is closely connected with mitochondria because mitochondria are the 
major source of ROS. In order to examine changes of mitochondria before the tissue loss, 
we examined changes of mitochondrial protein expression in cortex 1 h and 24 h post 
injury. Additionally, hippocampal mitochondrial protein levels were also evaluated at the 
same time points.  
4.3.1 Mitochondrial Proteomics of Cortex 
Previous studies show that ATP depletion, increased oxidative stress, cytochrome 
c release, and compromised mitochondrial function follow TBI (Xiong et al., 1997b; 
Sullivan et al., 1998; Lewen et al., 2001; Lifshitz et al., 2004).  Lifshitz et al. showed 
significant morphologic and integrity damage, and reduced mitochondrial proteins 
isolated from mitochondria in injured cortex and hippocampus at 3 h and 24 h post injury 
using a fluid-percussion model (Lifshitz et al., 2003; Lifshitz et al., 2004). Mitochondrial 
dysfunction involves multiple proteins, which indicates a very complicated process 
(Nicholls and Budd, 2000). Although reduced mitochondrial protein was isolated from 
brain tissues of animals following TBI, individual mitochondrial protein expression 
levels in isolated mitochondria were not investigated. Mitochondrial proteomics could 
investigate multiple proteins involved in the dysfunction. In the present study, 
mitochondrial protein expression in IP and CON tissues of animals subjected to TBI was 
quantified relative to animals subjected to sham surgery. The majority (75.7%) of the 
proteins identified were mitochondrial according to the Swiss-Prot database, and included 
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proteins involved in energy metabolism, small molecule transport, and mitochondrial 
outer membrane permeability. 
 Respiratory chain damage is widely investigated in other neurodegenerative 
diseases, including Huntington’s disease, ALS, AD, Parkinson’s disease, and ischemia 
(Fiskum et al., 1999). Damage to the respiratory chain following TBI is supported by 
studies of mitochondrial respiration in TBI, that show damage to state 3 (Vink et al., 
1990; Xiong et al., 1997a; Sullivan et al., 2005). In our study, we show levels of some 
subunits of complex III, and IV were significantly reduced 24 h post injury. Complex III, 
also known as the cytochrome bc1, oxidize ubiquinol (ubihydroquinone) which reacts in 
one membrane phase, reduces cytochrome c in the intermembrane space (or periplasm in 
bacteria), and use the free energy change to drive H+/QH2 across the membrane from the 
matrix to the inner membrane space. It is suggested that this complex is one of the major 
sites for electron leakage. Mitochondrial cytochrome c-1 is a collapsed di-heme 
cytochrome (Baymann et al., 2004), that was not changed 1 h post injury in IP cortex, but 
was increased in CON cortex, and reduced in IP cortex 24 h post injury. Ubiquinol-
cytochrome-c reductase complex core protein 2 was not changed 1 h post injury in IP, but 
was increased in CON cortex. Levels of the protein were decreased in both IP and CON 
cortices 24 h post injury. The decrease of the two complex III subunits could lead to 
significant electron leakage and oxidative damage to cell. Complex IV (cytochrome 
oxidase complex) is the site that oxygen binds with protons to form water, with the 
formation of a proton gradient. There are three main subunits and ten small subunits for 
complex IV. Among the small subunits, the subunits cox5b is small globular proteins 
bound to the matrix side of the core, and the globular subunit cox6b1 faces the 
intermembrane space (Michel et al., 1998). Subunit cox6b1 binds a zinc ion of unknown 
function in a tetrahedral coordination. It is suggested that the small subunits act as 
regulators and bind effectors and are required for complex assembly (Kadenbach, 1986). 
A previous study showed reduced cytochrome oxidase activity followed TBI (Hovda et 
al., 1991). Our data show cox5b (cytochrome c oxidase polypeptide Vb) levels decreased 
significantly 24 h post injury in both IP and CON cortices, but were not changed 1 h post 
injury in IP or CON cortex. In spinobulbar muscular atrophy disease, it has been shown 
that sequestration of cox5b by human androgen receptor (hAR) leads to mitochondrial 
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dysfunction (Beauchemin et al., 2001). In cancer cells, cox5b up-regulation increases 
retention of cytochrome c and enhances synthesis of ATP (Wu et al., 2000; Wu et al., 
2003). So the decrease of cox5b expression after TBI in both IP and CON cortex may 
lead to mitochondrial dysfunction and reduced ATP production. The difference of this 
polypeptide levels between 1 and 24 h post injury indicates a time dependent change. In 
addition, another subunit of complex IV, cox6b1 (cytochrome c oxidase polypeptide 
VIb), decreased 24 h post injury in IP cortex.  The compromised subunits of complex I, 
III and IV could lead to respiration deficiency that could lead to secondary respiratory 
deficiencies (Rotig et al., 2004) that . The respiratory deficiency could lead to significant 
electron leakage, and perturb proton transport and proton gradient. The proton gradient is 
the driving force for ATP production by complex V.  
 The TCA cycle involves multiple enzymes and is a key process for ATP 
production in mitochondria. Our data show dihydrolipoyl dehydrogenase and alpha-
ketoglutarate dehydrogenase are decreased significantly 24 h post injury in IP cortex, but 
not in CON cortex at this time point and IP and CON cortex 1 h post injury. 
Dihydrolipoyl dehydrogenase is a common component in three α-keto acid 
dehydrogenase complexes, including pyruvate, α-ketoglutarate and branched-chain α-
keto acid dehydrogenase complexes (Reed, 1974). This enzyme catalyzes the reoxidation 
of the dihydrolipoyl prosthetic group attached to the lysyl residue(s) of the 
acyltransferase components of the three α-keto acid dehydrogenase complexes. 
Reoxidation of the dihydrolipoyl group generates FADH, which can reduce NAD+ to 
NADH. Alpha-ketoglutarate dehydrogenase is a component of the alpha-ketoglutarate 
dehydrogenase complex, along with dihydrolipoamide succinyltransferase (E2) and 
lipoamide dehydrogenase (E3). This complex catalyzes the overall conversion of alpha-
ketoglutarate to succinyl-CoA and CO2 with production of NADH. Decreased levels of 
proteins could compromise the TCA cycle and production of NADH, which could lead to 
ATP depletion in tissues following TBI. Previous studies show alpha-ketoglutarate 
dehydrogenase complex deficiencies lead to cytochrome c release (Huang et al., 2003). It 
was also shown this enzyme was mediator of oxidative stress and mitochondrial 
dysfunction (Gibson et al., 2005). So the decrease of alpha-ketoglutarate dehydrogenase 
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could lead to deficiency of the enzyme complex and lead to mitochondrial dysfunction, 
cell apoptosis and neuron degeneration. 
Creatine kinase, an enzyme involved in energy transport is also a component of 
the MTP (Brdiczka et al., 1994). Our data show this enzyme was increased in CON 
cortex 1 h post injury, which suggests a compensatory response of cells to generate more 
ATP at this time point. Hexokinase 1 (HK1) and glyceraldehydes-3-phosphate 
dehydrogenase (GPDH) are key enzymes of cellular glycolysis, and are closely 
associated with mitochondria. HK1 is suggested to promote VDAC channel closure and 
prevent mitochondria mediated apoptotic cell death by inhibiting cytochrome c release 
(Azoulay-Zohar et al., 2004; da-Silva et al., 2004). HK1 may affect ATP production by 
affecting the supply of ADP (Birnbaum, 2004). Previous studies shows enhancement of 
glycolysis with a Pasteur effect, a shift from slow aerobic to rapid anaerobic consumption 
of glucose, after respiratory inhibition (Kauppinen and Nicholls, 1986). Our Western blot 
analyses showed increased HK1 expression following injury (data not show), which may 
show the Pasteur effect. However, the mitochondria-bound HK1 decreased significantly 
at 24 h post injury. The decrease of mitochondria-bound HK1 could lead to outer 
membrane permeability changes and cytochrome c release 24 h post injury in IP cortex. 
GPDH was thought to be a housekeeping protein, and regulate apoptosis by the 
inactivation of cytoprotective heat shock protein 70 (HSP70) in neurodegenerative 
disease and aging (Ishitani et al., 1996; Kragten et al., 1998; Chuang et al., 2005). It has 
been shown that more GPDH was deposited on mitochondria in cells undergoing 
apoptosis than cells under normal conditions (Saunders et al., 1997). Our data show 
GPDH levels in IP cortex increased as a trend at 24 h post injury. The increased GPDH 
may contribute to cell apoptosis and neuron dysfunction. Another key protein in 
apoptosis, VDAC, was shown decreased significantly in IP cortex 24 h post injury.  
Western blot analysis shows the same result as ICAT proteomics. VDAC is a key protein 
regulator of outer membrane permeability, which permits influx or efflux of molecules ≤ 
1500 Da. In addition, VDAC is a also key component of the MTP formed under stress, 
other members including ANT in the inner membrane, cyclophilin D (CypD) in the 
matrix, creatine kinase in intermembrane space, and hexokinase in the outer membrane 
(Verrier et al., 2003). Our data show VDAC (1 & 3) levels decreased significantly in IP 
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cortex 24 h post injury, but not 1 h post injury. VDAC plays a key role in exchange of 
metabolites and metal ions between mitochondria and cytoplasm (Rostovtseva et al., 
2005). The protein decrease may lead to decreased permeability resulting in slower 
response to calcium (Lifshitz et al., 2003).  Our study identified ADP/ATP carrier protein 
(ANT 1), and showed a significant increase 1 h post injury, which may indicate a 
compensatory response to injury. Buck et al. showed increased ANT1 facilitated 
glutamate transport (Buck et al., 2003). The ANT1 level increase 1 h post injury in IP 
cortex and may indicate the neurons’ response to reduce the excess glutamate released 
following TBI. 
Carrier proteins play an important role in mitochondrial function. Cytosolic 
NADH is transported into mitochondria for oxidative metabolism and ATP production 
through two NADH shuttles, including the malate/aspartate shuttle (LaNoue and 
Schoolwerth, 1979). The shuttle requires aspartate/glutamate carrier, which has two 
isoforms (aralar 1 and citrin) (Brown, 1992). The overall structure of citrin is similar to 
that of aralar 1, and both have four EF-hand Ca2+ -binding motifs in their N-terminal 
domains (del Arco and Satrustegui, 1998). Previous studies show recombinant expression 
of aralar 1 and citrin increased ATP production by stimulation of Ca2+-mobilizing 
agonists, in which aralar 1 and citrin function to decode calcium signals from cytosol for 
mitochondria (Palmieri et al., 2001; Lasorsa et al., 2003). It was also shown that aralar 
knock-out mice are growth-retarded, exhibited generalized tremoring, and had 
pronounced motor coordination defects along with an impaired myelination in the central 
nervous system (Jalil et al., 2005). Our data show calcium-binding mitochondrial carrier 
protein aralar 1 and mitochondrial glutamate carrier 1 (citrin) expression levels decreased 
as a trend in IP cortex 24 h post injury. The compromised protein expression could 
decrease NADH transport, ATP synthesis, and myelin lipid synthesis. However, the two 
proteins showed increased levels in CON cortex 1 h post injury, which could increase 
ATP production in CON cortex at this time point. 
Mitochondria are dynamic organelles, and their fission and fusion could produce 
new mitochondria or repair damaged mitochondria. Lifshitz et al. (2003) showed that 
reduced mitochondrial proteins isolated following TBI in cortex. Our data showed even 
in intact mitochondria or slightly damaged mitochondria, protein or polypeptide levels 
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related to energy metabolism, transport, and mitochondrial transition pore are decreased. 
Lower levels of key mitochondrial proteins could lead to mitochondrial dysfunction and 
significant oxidative stress, which could reduce mitochondrial protein yield (Cahill et al., 
1997). 
4.3.2 Mitochondrial Proteomics of Hippocampus  
 Our proteomics study of cortical mitochondria following TBI showed significant 
changes in proteins involved in the respiratory chain, TCA cycle and the MTP 24 h post 
injury, especially in IP cortex. In cortical TBI, hippocampus receives less mechanical 
injury although secondary injury was demonstrated. Mitochondrial damage was evident 
24 h post injury, as demonstrated by disrupted cristae, thinned outer membrane and 
ballooned appearance, and ATP depletion in CA3, but not CA1. In order to evaluate 
changes in mitochondrial protein levels in TBI, ICAT proteomics was carried out as 
described above. Twenty-nine proteins were identified in both IP and CON hippocampi 
at 1 and 24 h post injury, and 20 proteins showed significant changes. The proteins 
identified included proteins involved in energy metabolism, small molecule transport, and 
the MTP. 
Previous studies showed mitochondrial respiration was suppressed in 
hippocampus following TBI (Lifshitz et al., 2003) resulting in decreased ATP production. 
Complex I is one of the major electron entry points for the electron transport chain, and 
the largest and most complicated respiratory complex consisting of at least 46 subunits 
(Fearnley et al., 2001). Complex I defects are associated with neurodegenerative diseases 
and aging (Lenaz et al., 1997; Schapira, 1998). NADH-ubiquinone oxidoreductase B18 
subunit (NADH dehydrogenase [ubiquinone] 1 beta subunit 7), which functions to 
transfer electrons from NADH to ubiquinone with the generation of a proton gradient, is 
significantly decreased 24 h post injury in IP hippocampus, but increased in CON 
hippocampus. At 1 h post injury, this protein is maintained in IP and CON hippocampus. 
The decrease of NADH-ubiquinone oxidoreductase B18 subunit could lead to complex I 
dysfunction. In Complex III, our data show several protein subunits, including ubiquinol-
cytochrome-c reductase complex core protein 2 and ubiquinol-cytochrome C reductase 
complex 11 kDa protein, increased significantly 24 h post injury in IP hippocampus, 
although no significant changes were observed at 1 h. These changes show a different 
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response compared with cortical mitochondria. The increase of protein expression could 
improve the availability of these polypeptides in complex assembly and improve 
mitochondrial function. As for complex V, ATP synthase gamma chain increased in CON 
hippocampus 24 h post injury. The increase of protein expression 24 h post injury may 
indicate a compensatory response of cells to injury. Although ATP synthase gamma 
chain and ATP synthase subunit alpha decreased 1 h post injury in IP or CON 
hippocampus, the change is very small. 
The TCA cycle involves multiple enzymes and is a key process for ATP 
production in mitochondria. Citrate synthase, dihydrolipoyl (dihydrolipoamide) 
dehydrogenase, and glutamate dehydrogenase were significantly increased in IP 
hippocampus 24 h post injury. Citrate synthase is the first enzyme that controls the 
entrance of carbon into the TCA cycle (Krishnan et al., 2003). The increase of this 
enzyme may suggest upregulation of the TCA cycle in an effort to speed up energy 
metabolism. Increases of dihydrolipoyl dehydrogenase could lead to increased NADH 
production in IP hippocampus. Aconitate hydratase and malate dehydrogenase increased 
in CON hippocampus 24 h post injury. Increased aconitate hydratase could show 
increased TCA energy metabolism in CON hippocampus 24 h post injury. Isocitrate 
dehydrogenase [NAD] subunit alpha increased 1 h and 24 h post injury in CON 
hippocampus. Increases of malate dehydrogenate and isocitrate dehydrogenase [NAD] 
subunit could increase NADH production. Aspartate aminotransferase, another enzyme 
identified in this study is thought to be expressed in liver and heart, was shown increased 
levels at 24 h post injury in brain hippocampus. The increase of the protein suggests a 
compensatory response of mitochondria, and tries to produce more substances for ATP 
production. 
Our study also identified proteins involved in glycolysis, protein transport and 
folding, and formation of the mitochondrial transition pore (MTP). Hexokinase 1, a 
member of the glycolitic pathway and the MTP, was decreased in IP cortex 1 h post 
injury. In contrast, it increases to control levels 24 h post injury. Similar trends were 
observed in CON hippocampus at this time point. The increase of HK1 could reduce 
cytochrome a release and inhibit cell apoptosis. These data suggest the presence of 
mitochondrial recovery or repair following TBI. A carrier protein, adenine nucleotide 
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translocator 1 (ANT1), functions to transport ATP and ADP in oxidative phosphorylaion. 
Our data show ANT1 levels increase in IP and CON hippocampus 24h post injury, which 
suggests increased mitochondrial metabolism at this time point in both IP and CON 
tissues. Voltage-dependent anion-selective channel protein 1 (VDAC1) and voltage-
dependent anion-selective channel protein 3 (VDAC3) are key proteins regulating 
permeability of the outer membrane of mitochondria (Rostovtseva et al., 2005). Our data 
showed the two protein expression levels decreased slightly in IP hippocampus 1 h post 
injury, and maintained in IP hippocampus at 24 h post injury. VDAC3 levels go up in 
CON hippocampus at 24 h post injury. The decrease of the proteins may delay response 
to calcium in IP hippocampus 1 h post injury. The increase of pore proteins in CON 
hippocampus 24 h post injury may increase mitochondrial response to calcium. Heat 
shock protein, HSp60, is increased in CON hippocampus 24 h post injury. Previous 
studies show HSP60 levels increased in cerebrospinal fluid following TBI (Lai et al., 
2006).   
Mitochondrial precursor protein import receptor was shown to be significantly 
increased in CON hippocampus 1 h post injury. The increased protein level could 
indicate cells are trying to increase uptake of nuclear coded protein levels in 
mitochondria, and mitochondrial repair and recover. 
Lifshitz et al. showed mitochondrial damage and diminished calcium response in 
hippocampus using fluid-percussion injury model (Lifshitz et al., 2003). In cortex, our 
data show protein levels related to the respiratory chain, TCA and carrier proteins and 
MTP proteins decreased, which agree with the damage described by Lifshitz et al. Our 
data from hippocampus show that those proteins in isolated mitochondria increased 
following injury. It is interesting to note that the mitochondria in hippocampus showed an 
earlier response to TBI than cortex even though it receives less mechanical injury. 
However, Lifshitz et al. showed hippocampal mitochondria received less damage than 
cortical mitochondria. It is possible that the mitochondrial repair mechanism by 
multimitochondrial fusion lead to an increase in levels of some proteins in isolated intact 
hippocampal mitochondria (Busch et al., 2006; Chan, 2006). The increased levels of 
critical proteins in intact mitochondria may speed up ATP production in cells and 
compensate the consequence of some mitochondrial damage.  Mitochondrial 
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channel protein levels were maintained and other energy metabolic related enzyme 
increased in our study. However, Lifshitz et al. showed reduced CsA-sensitive and CsA-
insensitive swelling and deficits of the respiratory chain following fluid-percussion 
injury. Our data showed increased oxidative stress in hippocampus following TBI. It is 
possible that oxidative damage in mitochondria lead to dysfunction of channel proteins 
involved in mitochondrial membrane permeability (Singh et al., 2006).  
4.4 Protective Property of Creatine in TBI 
The aging study in TBI shows significant oxidative damage. These data suggest 
treatment of TBI patients with antioxidants may be helpful in recovery. Creatine is shown 
to have antioxidant properties, and also enhance energy storage and stabilization of the 
mitochondrial permeability transition pore (MTP) (O'Gorman et al., 1997; Sullivan et al., 
2000; Wyss and Kaddurah-Daouk, 2000). Previous studies show creatine protects against 
glutamate, 1-methyl-4-phenylpyridinium (MPP+) and β-amyloid toxicity, and blocks 
oxidative damage and inhibits cytochrome c release (Klivenyi et al., 1999; Matthews et 
al., 1999; Brewer and Wallimann, 2000; Brustovetsky et al., 2001; Scheff and Dhillon, 
2004; Zhu et al., 2004; Bender et al., 2005). The present data suggest creatine reduces 
oxidative stress and increases antioxidant enzyme capacities in TBI. 
In TBI, the hippocampus undergoes significant neuron degeneration and 
significantly increased lipid peroxidation 1 and 7 days post injury. In cortex, primary 
mechanical brain injury causes cell death in the impact zone that likely involves 
complicated processes such as oxidative stress that are evident 1 and 7 days post injury. 
Previous studies show creatine supplementation significantly reduces free fatty acid 
levels in TBI and inhibits oxidative injury in animal models of amyotrophic lateral 
sclerosis (ASL) (Klivenyi et al., 1999; Scheff and Dhillon, 2004). Our data show levels of 
HNE were significantly reduced in IP hippocampus and cortex of creatine treated animals 
compared to animals with a regular diet. Previous studies also show creatine 
supplementation increased creatine and phosphocreatine (Pcr) stores in brain (Dechent et 
al., 1999). Creatine kinase, creatine and phosphocreatine play a key role in energy 
buffering and transport, and can help reduce glutamate toxicity and maintain Ca2+ 
homeostasis, which may block oxidative processes (Hemmer and Wallimann, 1993; 
Wallimann and Hemmer, 1994; Bender et al., 2005). In addition, creatine can stimulate 
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oxidative phosphorylation and inhibit mitochondrial transition pore opening, which can 
increase bioenergetic synthesis and may prevent leakage of ROS from mitochondria 
(Wallimann et al., 1992; Kay et al., 2000; Meyer et al., 2006). 
Our study shows creatine can improve antioxidant capacities, which can 
contribute to reduced oxidative stress. Previous studies show SOD activity decreases 
following TBI. The experiments conducted in this study show that Cu/ZnSOD activity 
was significantly increased to near CON levels in IP cortex and hippocampus of creatine 
treated animals compared with regular diet animals. It is possible that increased 
phosphocreatine level in cytosol helps to direct protein repair by such enzymes as HSP70 
and disulfide isomerase following injury to maintain the enzyme pool with normal 
function and lead to higher enzyme activity (Lu et al., 2001; Hansel et al., 2002; Kregel, 
2002). MnSOD was significantly increased to CON levels in IP hippocampus of creatine 
treated animals compared with controls, but no significant difference was observed in IP 
cortex. The mitochondrial proteomics study showed mitochondria were severely 
damaged in cortex, which could result in ATP shortage in the mitochondria for MnSOD 
folding and repair. Unfortunately, phosphocreatine in cytosol may not help since the 
disruption is primarily mitochondrial. Mitochondria in hippocampus receive less damage, 
and ATP production and enzyme repair may be maintained. The increase of SOD 
improves the cell’s ability to remove superoxide generated after TBI and reduce lipid 
peroxidation. Previous studies show Vitamins C and E reduce oxidative stress and 
increase antioxidant capacities (Murugesan et al., 2005). Because creatine can function as 
a direct antioxidant (Lawler et al., 2002) it can neutralize ROS and reduce oxidative 
damage in a similar fashion as Vitamins E and C. 
Glutathione peroxidase reduces hydrogen peroxide to water with consumption of 
glutathione. Previous studies show GPx activity increased following TBI since this 
enzyme is greatly induced by oxidative stress (DeKosky et al., 2004). Our data show GPx 
activity decreased in IP tissues in animals with creatine supplementation compared to 
controls. Aging studies show dietary restriction extends life by reducing oxidative stress. 
Meanwhile, dietary restriction reduces GPx activity in aging (Baek et al., 1999). Reduced 
GPx could be an indicator of less oxidative stress, although diminished activity may 
accelerate oxidative damage in IP tissues. Lindenau et al. (Lindenau et al., 1998) reported 
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that GPx was localized predominantly in microglia in CNS, and was shown to be 
upregulated in microglia and astrocytes, but not in neurons after CNS lesion. Based on 
previous studies showing that TBI initiated an inflammatory response and led to neuron 
damage (Lu et al., 2005), our data suggest that creatine may inhibit microglia and 
astrocyte activation, and GPx expression. 
Glutathione transferase can alleviate oxidative damage by catalyzing conjugation 
of glutathione (GSH) with nucleophilic lipid peroxidation products, especially aldehydic 
by-products (HNE and acrolein). In this study, GST activity increased significantly in IP 
hippocampus of animals provided with a 2% creatine diet. GST activities showed a 
significant dose dependent increase among the three groups. An increase in GST activity 
suggests creatine improves the animal’s capacity to decrease oxidative damage. In 
contrast to cortex, GST activity did not change in the hippocampus. Glutathione 
reductase, which functions to regenerate reduced glutathione, showed reduced activity 
following TBI in our previous study. Our current study shows a significant increase in 
GSSG-R in IP cortex of creatine supplemented animals. An increase of GSSG-R activity 
suggests the cortex may have a greater capacity to maintain the reductive environment 
following TBI compared to control, which can protect cells from damage. 
Creatine supplementation significantly reduced lipid peroxidation, especially the 
amount of HNE, which is the major products of lipid peroxidation and is believed to be 
an important marker in oxidative stress (Esterbauer et al., 1991). Although no statistically 
significant differences in acrolein levels were observed in cortex and hippocampus, the 
trend showed levels of acrolein were reduced in animals provided a creatine 
supplemented diet (Lee et al., 2006). Animals provided creatine supplementation did not 
show alterations in oxidative damage or antioxidant capacity in CON cortex or 
hippocampus suggesting creatine functions in injury. In addition, 2% creatine 
supplementation did not show more protection than 1%, except for GST in IP 
hippocampus in present study. 
 
Copyright © Changxing Shao 2007 
 112
CHAPTER FIVE 
Conclusion 
 TBI is a major public health concern in industrialized nations primarily due to 
motor vehicle accidents. TBI is a tragedy for patients and their families, and costs about 
$20 billion for treatment annually in the US. Additionally, improved living conditions 
have led to extended longevity of humans, and a significant increase of the number of 
people age 65 and over. Elderly subjects 75 years or older, show higher death rates 
following brain injury due to motor vehicle accidents or falls.  
 TBI patients suffer a variety of potential problems because of neuron damage near 
and remote from the site of injury. Studies to assess neuronal damage following TBI is 
the key to finding effective treatments. Research over the past 30 years suggestes the 
pathology of TBI occurs at the cellular and molecular level. Currently, it is widely agreed 
that secondary injury is important in neurodegeneration following TBI. Current data 
suggest the primary mechanical injury is not treatable, leaving secondary injury as the 
best hope for treatment in TBI. Although excess excitatory amino acids, mitochondrial 
dysfunction, oxidative damage, adenosine and triphosphate adenine nucleotide depletion, 
inflammatory events, ion homeostasis disruption, proteolytic enzymes activation, DNA 
damage, and cholinergic receptor dysfunction have been shown to contribute to 
secondary injury, the exact mechanism is still unclear. We hypothesize oxidative damage 
and compromised antioxidant capacity contribute to neurodegeneration following TBI. 
This dissertation described oxidative damage and mitochondrial changes in TBI. 
 In human TBI, computed tomography can be performed immediately following 
injury to evaluate tissue damage by measuring the size of infarct or hemorrhage in the 
brain. At the site of mechanical injury, tissue loss or shrinkage is observed following 
neuronal death or damage hours, days or weeks post injury. Neurons are the basic unit of 
brain, and neuron loss could lead to series of problems for patients even though they 
survived. Severity of neuronal loss or damage indicates the more severe injury patients 
suffer, and the more problems patients could carry in the future. Unfortunately, neurons 
cannot regenerate although current studies are aimed at regeneration of neurons by 
transplant. 
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 The work described in this dissertation is the first to measure tissue sparing 
following TBI as a function of age using Fisher-344 rats subjected to a controlled cortical 
impact injury. Although human subjects can suffer injury at any area of the brain and 
injury is probably more complicated, the animal model used in current study can mimic 
pathology in human brain injury. In our study, significant tissue loss was observed 7 days 
post injury, and showed an age-dependent increase in aging. This is the first study to 
show tissue sparing in TBI in aging using young, middle aged and aged animals. The 
increase of tissue loss in aging may lead to more problems for aged animals. These 
results suggest the aged brain is more fragile and aged neurons are less durable than 
young ones.  
However, an interesting question is why the response of aged brain is different 
from young brain following TBI. The answer to this question could significantly improve 
our understanding of the mechanism of secondary injury in aging and led to improved 
treatment of aged patients. This dissertation showed significant lipid peroxidation and 
DNA oxidation in cortex and hippocampus following TBI in each age group that 
increased in an age dependent format. This is the first study to evaluate oxidative damage 
in TBI in aging. Lipid peroxidation is the consequence of oxidative damage to 
polyunsaturated fatty acids, leading to formation of aldehydic byproducts that modify 
proteins and DNA and lead to further damage to cell. DNA damage can lead to gene 
mutations and affect transcription and protein expression, leading to alteration in normal 
cellular function. Because the animal model used in current study mimics human TBI, 
our results suggest oxidative damage may also happen in human brain. Additionally, the 
data described in the dissertation showed an age-dependent increase of lipid peroxidation 
following TBI, which could lead to aged neurons more fragile than young neurons.  
The increase of oxidative damage and its age-dependent changes following TBI 
suggest cellular defenses toward oxidative damage may be compromised following TBI 
and are probably affected by age. So we measured the antioxidant enzyme activities 
following TBI. We measured MnSOD, Cu/ZnSOD, GPx, GSSG-R, and GST activities, 
enzymes that play different rules at different stages in cellular defense. MnSOD and 
Cu/ZnSOD convert superoxide to hydrogen peroxide, and GPx converts hydroperoxides 
and to alcohols or water. GSSG-R helps to maintain the reduced glutathione pool, and 
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GST can detoxify xenobiotics and endogenously produced aldehydes, including lipid 
peroxidation byproducts. Since MnSOD is located in mitochondria where most ROS are 
produced, it is probably more important than other enzymes. Small changes in this 
enzyme may lead to mitochondrial damage by superoxide and compromise ATP 
production, leading to energy shortage in cells. Because most biological reactions are 
ATP dependent, the ATP shortage could slow down or shut down most biological 
process, leading to cell dysfunction. We observed significant decrease of MnSOD in 
cortex following injury with aged animals showing more pronounced loses than young 
adults. In the hippocampus, young animals maintained MnSOD activity until 24 h post 
injury, and decreased 7 days post injury. But for middle aged and aged animals, MnSOD 
decreased significantly beginning 24 h post injury. These results suggest aged animals 
may have diminished capacities to remove superoxide leading to increased damage in 
mitochondria. Cu/ZnSOD decreased in cortex 24 h and 7 days post injury. The decrease 
of Cu/ZnSOD activity suggests damage in oxidative defense in cytoplasm. It is 
interesting to note that MnSOD activity changed earlier than Cu/ZnSOD in hippocampus, 
and decreased at 7 days post injury but Cu/ZnSOD did not. It is possible that oxidative 
damage begins in mitochondria and spreads to cytosol. In cortex, young animals showed 
a loss of Cu/ZnSOD activity 24 h post injury, and middle aged and aged animals showed 
decreased Cu/ZnSOD 7 days post injury. MnSOD activity did not change in young 
animals 24 h post injury, and decreased 7 days post injury, suggesting different responses 
in cortex and hippocampus.  
In cells subjected to oxidative damage, mitochondria are thought to be critical 
important as the major source of ROS. Our data show a significant loss of MnSOD 
following TBI. An understanding of mitochondrial changes following TBI may help yield 
clues for TBI treatment. For example, with an understanding of what is going on in 
neuronal mitochondria following TBI, it might be possible to target mitochondria in 
patient treatment. In order to investigate changes in mitochondria following TBI, we 
carried out studies of mitochondrial protein. Our data show mitochondrial protein 
expression changes in cortex and hippocampus at 1 h and 24 h post injury. This is the 
first study to examine how mitochondrial protein changes in isolated mitochondria 
following TBI. An early time point (1 h) was selected for this study because previous 
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studies from other labs showed early changes in mitochondria following TBI. We used 
the isotope-coded affinity tag (ICAT) method to label mitochondrial proteins, and 
following protein trypsinization and peptide purification, peptides were sequenced and 
quantified using 2D LC/MS/MS. ICAT analysis of mitochondria from cortex and 
hippocampus showed different responses to injury. Proteins or polypeptides of proteins 
from the respiratory chain, and TCA cycle and channel proteins decreased significantly in 
cortex 24 h post injury. In contrast, increased protein levels were observed in 
hippocampus at this time point in both IP and CON hippocampus. A decrease of complex 
I to complex V polypeptides in cortical mitochondria could lead to deficiencies of there 
complexes, and an increase of ROS leakage, reducing the proton gradient and ATP 
synthesis. ROS leakage could damage unsaturated fatty acids and the enzymes in 
mitochondria, including MnSOD, leading to increased oxidative damage in cytosol. 
Decreased levels of shuttle proteins for NADH transport from the cytosol to mitochondria 
could lead to shortages of NADH in mitochondria for the electron transport chain. 
Additionally, deficiencies in the TCA cycle following TBI could result in increased 
NADH shortages. Voltage gated channel proteins function to regulate permeability of 
outer membrane of mitochondria, and the observed decrease of their expression levels in 
cortex could compromise metabolite exchanges between cytosol and mitochondria, 
including ATP and calcium. These changes in mitochondria following TBI could shut 
down mitochondrial function, leading to neuron dysfunction or death by triggering 
apoptosis or necrosis. In the hippocampus, an increase of TCA enzymes could increase 
NADH synthesis for the respiratory chain, and increased electron transport. However, we 
observed one polypeptide, NADH-ubiquinone reductase B18 subunit that was 
significantly decreased. Although function of this protein is unclear, the deviation of its 
levels from normal may diminish the respiratory chain. Channel protein and heat shock 
protein expression levels increase 24 h post injury in hippocampus. The increase of 
VDAC protein could increase the permeability of outer membrane of mitochondria and 
speed up metabolite and ion exchange between cytosol and mitochondria, and increase 
the response to calcium following injury. Although previous studies by Lifshitz eta al. 
(2003) showed mitochondrial shape changes and damage to the respiratory chain in 
hippocampus following fluid percussion injury, our data showed protein levels increase 
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in mitochondria. Hall et al. (2006) showed increased oxidative damage in mitochondria 
following TBI. It is possible that oxidative damage in mitochondria lead to mitochondrial 
deficits even though increased mitochondrial proteins. For future studies, we want to 
elucidate why the mitochondrial protein expression changes following TBI and how 
oxidative damage affects individual proteins in mitochondria. 
 The data described in this dissertation showed oxidative damage and changes in 
mitochondrial proteins following TBI, and these could lead to neuron dysfunction. We 
observed compromised antioxidant capacity in our study. If we can find a method to 
reduce oxidative damage through increased antioxidant defenses and protect 
mitochondria following TBI, it could be very helpful in the recovery of TBI patients. 
 Creatine is an endogenously synthesized small molecule in liver and kidney, and 
is released to blood stream in human and other mammals. Creatine can cross the blood 
brain barrier through a specific creatine transporter CRT, so its possible creatine may be a 
good candidate drug to reduce oxidative damage and protect mitochondria. Clinical 
studies in muscle disease showed creatine did not show side effects on patients (Felber et 
al., 2000). Previous studies have shown oral or intracerebroventricular creatine to be 
neuroprotective in PD, ALS, spinal cord injury and TBI. Pilot study carried out with 34 
patients from 1 to 18 years old showed creatine was beneficial to TBI patients with no 
side effects observed in an oral administration at a dose of 0.4 gr/kg (Sakellaris et al., 
2006). The administration of creatine to TBI patients improved patients in several 
aspects, including duration of post-traumatic amnesia, duration of intubation, intensive 
care unit stay, disability, general recovery, self care, communication, locomotion, 
sociability, personality/behavior and neurophysical, and cognitive functions. Significant 
improvement was recorded in the categories of cognitive, personality/behavior, self care, 
and communication. Unfortunately, the mechanism by which creatine is unclear. To 
determine if creatine can reduce oxidative damage, we provided animals a creatine 
enriched diet prior to injury. The results described in this dissertation showed animals 
with creatine supplementation had significantly reduced lipid peroxidation following 
TBI. But how does creatine work to reduce oxidative damage? Further studies showed 
SOD increased in animals with a creatine diet. GSSG-R and GST also increased in IP 
tissues of animals with creatine supplementation. So we believe creatine can reduce 
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oxidative damage through increased antioxidant defenses, thus protect neurons. Of 
course, further studies are needed to elucidate how creatine administration affects 
antioxidant enzyme activity.  
Altogether, creatine, an endogenously synthesized small molecule, showed 
benefitial function in primary clinical studies with small populations of patients. Previous 
studies in other research groups show creatine can protect mitochondria through 
regulation of MTP. Our data show creatine can reduce oxidative damage by increased 
antioxidant enzyme activities. This is the first study to evaluate how creatine affects 
antioxidant defense in vivo. This new study improved our understanding the function of 
creatine, and further approved the beneficial effects of creatine supplementation to 
patients with brain injury. We believe creatine may be a potential therapeutic for TBI 
patients. Although, more clinical studies are needed, including post injury treatment 
studies, pharmaceutical studies for the optimum dose.  
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Appendix 
Nomenclature 
Abbreviations:  AD, Alzheimer’s disease; ALS, amyotrophic lateral sclerosis; CON, 
contralateral; Cu/ZnSOD, copper/zinc superoxide dismutase; FA, fapyadenine; FG, 
fapyguanine; GPx, glutathione peroxidase; GSSG-R, glutathione reductase; GST, 
glutathione transferase; HNE, 4-hydroxynonenal; IP, ipsilateral; ROS, reactive oxygen 
species; MnSOD, manganese superoxide dismutase; PD, Parkinson’s disease; TBI, 
traumatic brain injury; MPT, mitochondrial permeability transition; 8-OHG, 8-
hydroxyhuanine; 8-OHA, 8-hydroxyaenine; 5-OHC, 5-hydroxycytosine; CCI, cortical 
controlled injury 
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